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Summary 
Helicobacter pylori is a Gram-negative gastric pathogen that infects approximately half 
of the world population. H.pylori infection is associated with many gastric diseases like 
gastritis, peptic ulcers and gastric cancer. Especially, translocation of the cytotoxin-
associated gene A (CagA) protein via the cag-type IV secretion system (cag-T4SS) into 
host gastric epithelial cells is a major risk factor for developing gastric cancer. However, 
the exact molecular mechanism of CagA translocation into host cells and host factors 
involved in this process are not well characterized. Previously, host cell integrin β1 was 
reported to be exploited by the H.pylori cag-T4SS for CagA translocation. In addition, 
host carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) were 
recently identified to interact with the H.pylori adhesin HopQ to contribute to CagA 
translocation.  
In order to study the role of host cell integrin in CagA translocation and to identify other 
integrins (besides integrin β1) which might be exploited by H.pylori, the CRISPR-Cas 
system was applied to generate single to multiple integrin depletion AGS and KatoIII 
gastric epithelial cell lines. By targeting the integrin β1, αv and β4 genes first 
individually, then simultaneously, all 17 potential non-leukocyte and non-platelet 
integrins, including 9 epithelial-specific integrins were systematically depleted on the 
cell surface. CagA translocation efficiency was subsequently evaluated in each integrin-
depletion cell line by a quantitative β-lactamase dependent reporter assay. 
Unexpectedly, the CagA translocation efficiency was not found to be reduced in AGS 
cells in the context of single or multiple integrin depletion. However, CagA translocation 
efficiency was compromised in KatoIII cells, not because of the absence of host cell 
integrins, but because of decreased CEACAM5 and CEACAM6 expression which has 
been induced by integrin depletion.  
Therefore this work describes for the first time a novel CagA translocation mechanism 
into gastric epithelial cell lines (AGS and KatoIII) in vitro, which is completely 
independent of host cell integrins. In addition, the data confirmed that the HopQ-
CEACAM interaction is necessary for CagA translocation. Besides the CEACAMs, 
probably other unknown host receptors are exploited by H.pylori for CagA translocation.
Zusammenfasung 
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Zusammenfassung 
Etwa die Hälfte der Weltbevölkerung ist mit dem pathogenen Magenbakterium 
Helicobacter pylori  infiziert. Die Infektion mit H. pylori ist mit verschiedenen 
Magenerkrankungen wie Gastritis, Magengeschwüren und Magenkrebs assoziiert. 
Insbesondere die Translokation des Zytotoxin-assoziierten Gen A (CagA) Proteins in 
Magenepithelzellen des Wirtes, was durch das cag-Typ IV-Sekretionssystem (cag-
T4SS) ermöglicht wird, ist ein Risikofaktor für die Entstehung von Magenkrebs. Dennoch 
ist der exakte molekulare Mechanismus der CagA-Translokation in Wirtszellen sowie 
Wirtsfaktoren, die in diesen Prozess involviert sind, nicht genau charakterisiert. In 
früheren Studien wurde gezeigt, dass das Wirtszellintegrin β1 durch das cag-T4SS für 
die CagA-Translokation genutzt wird. Zusätzlich wurden Zelladhäsionsmoleküle der 
karzinoembryonalen Antigenfamilie (CEACAMs) identifiziert, welche mit dem H. pylori 
Adhesin HopQ interagieren und dadurch zur CagA-Translokation beitragen. 
Um den Einfluss von Wirtszellintegrinen auf die CagA-Translokation zu untersuchen und 
neue von H. pylori ausgenutze Integrine (neben Integrin β1) zu identifizieren, wurde das 
CRISPR-Cas System angewandt, um Integrine in epithelialen Magenadenokarzinom-
Zelllinien (AGS und KatoIII) zu depletieren. Indem die Integringene β1, αv und β4 sowohl 
einzeln als auch simultan inaktiviert wurden, konnten alle 17 nicht mit Leukozyten oder 
Thrombozyten assoziierten Integrine, einschließlich 9 mit Epithelien assoziierte Integrine, 
systematisch von der Zelloberfläche depletiert werden. Die CagA-Translokations-
effizienz wurde in jeder Integrin-depletierten Zelllinie mittels eines quantitativen β-
Lactamase Reporterassays bestimmt. Überraschenderweise war die CagA-
Translokationseffizienz in keiner der Integrin-depletierten AGS Zelllinien reduziert. 
Hingegen war die CagA-Translokationseffizienz in Kato III Zellen reduziert, was jedoch 
nicht auf die Abwesenheit der Wirtszellintegrine, sondern auf eine durch 
Integrindepletion induzierte Expressionsreduktion von CEACAM5 und CEACAM6 
zurückgeführt wurde. 
Daher beschreibt diese Arbeit erstmals eine von Wirtszellintegrin unabhängige CagA-
Translokation in epitheliale Magenadenokarzinom-Zelllinien (AGS and Kato III) in vitro. 
Zusammenfasung 
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Zusätzlich wurde die Relevanz der HopQ-CEACAM Interaktion für die CagA-
Translokation bestätigt. Neben CEACAMs könnten weitere, unbekannte Wirts-
zellrezeporten für die CagA-Translokation von H. pylori ausgenutzt werden.  
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1 Introduction 
1.1 The CRISPR-Cas system 
During the past 20 years, different genome engineering technologies have raised 
considerable attention. For the first time, molecular biologists were able to manipulate 
DNA molecules to investigate and elucidate their role and function in the context of the 
whole genome. This holds promises for the development of novel drugs and therapeutic 
strategies. Early genome editing tools include zinc finger nucleases (ZFNs) and 
transcription activator-like effector nucleases (TALENs). Both systems were designed 
as chimeric nucleases composed of sequence-specific DNA binding proteins fused to 
non-specific DNA cleavage modules. After introduction of site-specific double strand 
breaks (DSBs) by chimeric nucleases, DNA repair pathways are initiated to facilitate 
genome editing. However, these systems have their limitations, since they both exhibit 
context-dependent specificity due to the crosstalk between DNA binding modules and 
their target DNA sequences. In addition, the pre-design and post-screening processes 
are time-consuming, labor intensive and costly. Of the most thrilling invention is the 
recent discovery and application of the Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPR)-Cas system as a powerful alternative for genome 
engineering in a variety of cell types and organisms with high efficiency, easy design 
and low cost. 
The CRISPR-Cas system is naturally present in roughly 40% of sequenced bacteria and 
90% of archaea. It represents a prokaryotic adaptive immune defense system against 
viral infection. Different from ZFNs and TALENs, the CRISPR-Cas system uses short 
RNAs to guide nucleases for recognizing target DNA through Watson-Crick base paring 
and introducing DSBs specifically. Three broad groups (type I-III) of CRISPR-Cas 
systems have been identified across different bacterial and archaeal hosts. Each 
system comprises a CRISPR array, a cluster of CRISPR associated (Cas) genes and 
noncoding RNAs. CRISPR array is a regulatory array containing multiple signature short 
direct repeats, which are interrupted by similarly sized variable sequences termed 
“spacers” that derived from phages and invaders. Most CRISPR arrays are transcribed 
Introduction 
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and processed as mature CRISPR RNAs (crRNAs). Whereas Cas genes are typically 
adjacent to CRISPR arrays and are translated into nucleases, which subsequently form 
complexes with and are guided by crRNAs to the target DNA to introduce DSBs. In 
addition, non-coding RNAs in the system are required as tans-activating RNA to 
facilitate and support the DNA targeting. Comparing to typeⅠand type Ⅲ CRISPR loci 
which encode redundant and multiple Cas genes, the type Ⅱ loci contain significantly 
reduced numbers of Cas genes and are thus favored by scientists to harness for an 
genome editing tool. 
The CRISPR system was first reported in 1987 [1], Nakata and colleges were curious 
about the mysterious 29nt repeats downstream of the iap gene, when they studied 
alkaline phosphatase isozyme conversion in E.coli. After this, other components 
belonging to the system were identified one after the other. By 2005, more than one 
group found that the spacers derived from foreign genetic elements had phage-
associated origins [2, 3]. This was the first time for scientists to surmise the biological 
function of the CRISPR system — it might be involved in microbial adaptive immunity 
against bacteriophage attack. As the CRISPR story became more interesting, 
researchers accelerated their paces. By 2011, the basic structure and function of this 
system became clear [4, 5]. However, the potential of the CRISPR system as a 
powerful genome editing tool had not been explored until 2013, when two studies 
simultaneously showed the first experimental evidences of applying CRISPR system in 
eukaryotic cell lines for the purpose of gene editing [6, 7]. This sparked the beginning 
of a new era for eukaryotic genome engineering. From then on, many labs applied this 
powerful technology and hence the whole molecular biology research had accelerated 
greatly. 
Bacteria and archaea are under constant attacks from viruses and other invaders. Not 
surprisingly, they evolved a prokaryotic adaptive immune system against foreign DNA. 
Taken the type II CRISPR-Cas system as an example, the defense mechanism involves 
1.1.1 History of the CRISPR-Cas system development  
1.1.2 Working mechanism of the natural prokaryotic CRISPR-Cas system 
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two phases. In the first so-called “immunization” phase, the Cas protein complex 
cleaves the injected DNA from invading phages into small fragments and inserts them in 
the CRISPR array between the direct repeats as “spacers”. In the second “immunity” 
phase, the CRISPR array is transcribed as a long pre-crRNA, which recruits Cas9 
nucleases to form a complex. At the same time, trancrRNA, an auxiliary trans-
activating crRNA, is transcribed and binds to the repeat region of the pre-crRNA. 
Subsequently, RNase III recognizes the hybridized crRNA-trancrRNA and cleaves site-
specifically, producing short crRNAs which form a mature complex with both Cas9 and 
trancrRNA. Eventually, mature crRNAs guide Cas9 nucleases to the target DNA to 
introduce precise cleavages and to produce DSBs. In this way, foreign DNA is degraded 
and the harmful invaders are defeated.  
It is worth noting that recognition and cleavage of target DNA by the crRNA-trancrRNA-
Cas9 complex not only involves the Watson-Crick pairing between the spacer and the 
complementary target sequence (also termed as “protospacer”), but also the presence 
of a specific short sequence immediately following the 3’-end of the target, which is 
termed as protospacer adjacent motif (PAM). PAM differs according to its Cas9 
orthologue, for example, Streptococcus pyogenes requires NGG as the PAM, where N is 
any nucleotide [8]; Neisseria meningitides requires NNNNGATT [9, 10]. PAM is crucial 
for the system to distinguish between self and non-self to avoid autoimmunity since 
PAM doesn’t exist in the repeat region of the CRISPR locus. In this way, Cas9 can only 
recognize and cleave target DNA, but not the spacer in the CRISPR locus [11]. 
Wildtype Cas9 in type II system was reported to make a blunt-ended, double-stranded 
break 3 bp upstream of the PAM sequence [12]. Double strand breaks are a crucial 
first step for genome editing, since the DNA repair system can be triggered when the 
DSBs are created [13]. DSBs can be repaired either by nonhomologous end-joining 
(NHEJ) or by homology directed repair (HDR) in nearly all different cells and organisms 
[14]. In the absence of the repair templates, DSBs are re-ligated by the error prone 
NHEJ pathway, which results in random indel (insertion/deletion) mutations. Indel 
mutations within coding exons can lead to frame shift and downstream stop codons. 
Therefore, DSB repair in the absence of homologous templates can mediate gene 
knockout [15]. In the presence of the homologous templates, dividing cells can 
undergo high fidelity HDR, generating gene knockin or precise point mutations specified 
Introduction 
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by the provided exogenous templates [16]. The repair template can be designed as 
single-stranded DNA oligonucleotides (ssODN) [17, 18] which appears simple and 
effective. 
 
Figure 1.1 Working 
mecahnisms of type II 
CRISPR-Cas9 system 
(modified from Prashant 
Mali, 2013). In the first 
“immunization” phase, 
the Cas protein complex 
cleaves the injected DNA 
from invading phages 
into small fragments and 
inserts them in the 
CRISPR array between 
the direct repeats as 
“spacers”. In the second 
“immunity” phase, the 
CRISPR array is 
transcribed as a long pre-
crRNA, which recruits 
Cas9 nucleases to form a 
complex. At the same 
time, trancrRNA, an 
auxiliary trans-activating 
crRNA, is transcribed and 
binds to repeat region of 
the pre-crRNA. 
Subsequently, RNase III 
recognizes the 
hybridized crRNA-
trancrRNA and cleaves 
site-specifically, 
producing short crRNAs 
which form a mature 
complex with both Cas9 
and trancrRNA. 
Eventually, mature 
crRNAs guide Cas9 
nucleases to the target 
DNA to introduce precise 
cleavages and produce 
DSBs.    
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The specificity of the S.pyogenes Cas9 nuclease has raised considerable attention, 
since unexpected genome modifications could lead to unpredictable catastrophes 
especially for clinical gene therapy. Several studies have demonstrated that Cas9 could 
tolerate up to 5 mismatches between guide sequences and protospacers, which leads 
to off-target DNA cleavages [21-24]. The structure of Cas9 nuclease revealed, there 
are two signature catalytic domains responsible for cleavage of the double strand DNA: 
The HNH domain cleaves the strand which is complementary to the guide RNA, and the 
RuvC-like domain cleaves the non-complementary strand [8]. Several studies have 
converted SpCas9 into a nickase which produces single-stranded nicks by inactivating 
one of the catalytic domains [8, 19, 20]. To improve the nuclease targeting specificity, 
a double nicking strategy was applied in the CRISPR-Cas9 system with a pair of 
sgRNAs guiding Cas9 nickase targeting the opposite strands of the target site within an 
appropriate offset. Since nicks can be repaired without indel mutations by high fidelity 
base excision repair pathway, two nicks which are close enough and properly spaced 
can mimic the DSBs to induce indel formation. In this way, targeting specificity of a 
double nicking strategy is 1500 times higher than the wildtype Cas9 nuclease [24, 25]. 
  
1.1.3  Initial harnessing of the CRISPR-Cas system for biological research  
How does a mysterious prokaryotic adaptive immune system become the most powerful 
and robust eukaryotic genetic engineering platform? The story began in 2011, when 
Siksnys and colleagues first found out that the typeⅡ CRISPR-Cas system from 
Streptococcus thermophiles could be functionally reconstituted in E.coli [19]. After the 
inspiring initial research, several studies made great progresses in the next two years in 
harnessing the type II system from S. pyogenes and S. thermophiles in eukaryotic cells. 
Progress was made through modification of the key components including expression 
of a human-codon-optimized Cas9 nuclease with a nuclear localization signal, and 
expression of crRNA-trancrRNA as a single chimera, also known as the short guide RNA 
(sgRNA) [6, 8, 20].  
1.1.4 Specificity improvement of the CRISPR-Cas system  
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1.2 Helicobacter pylori 
In 1983, Warren and Marshall cultured slow growing microaerophilic bacteria and first 
reported an etiological correlation between these bacteria, later termed Helicobater 
pylori (H.pylori), and gastric diseases [26]. The outcome was remarkably surprising, 
since nobody expected microbes to survive in the highly acidic stomach. Because of 
this discovery, gastritis and peptic ulcers were no longer considered as chronic diseases 
caused by stress, but curable infections that can be treated with antibiotics and acid 
secretion inhibitors. Therefore, Warren and Marshall were awarded the Nobel Prize in 
Physiology or Medicine for 2005. 
H.pylori, Gram-negative bacilli which colonize half of the world’s population, are the 
main cause of gastritis, peptic ulcers, gastric lymphoma and even gastric 
adenocarcinoma. Of note, H.pylori-induced gastric cancer is one of the most common 
cancer and the second leading cause of cancer-related death worldwide.  It is 
dominantly transmitted orally in childhood within a family and the infection mostly 
persists life-long in the infected individual [27]. H.pylori have colonized human 
stomachs for at least 60,000 years [28] and they have developed many strategies to 
adapt to the hostile niche and to successfully evade and manipulate human immune 
recognition to facilitate their survival and persistence [29]. 
The normal stomach is highly acidic with a pH of 1-2. Many pathogens conferring 
acidic tolerance or acidic resistance like Vibrio cholerae or Escherichia coli, can take up 
amino acids to produce amine by decarboxylation to neutralize the cytoplasm and 
facilitate bacterial survival, but not colonization [30, 31]. However, H.pylori can 
colonize in the acidic lumen of the stomach by using a unique strategy called acid 
acclimation [32, 33]. Unlike acid resistance, acid acclimation can buffer the periplasm 
of H.pylori to a near neutral pH by utilizing abundant surface urease to hydrolyse urea 
into ammonia. Periplasm neutral pH is important for H.pylori colonization because it 
assures synthesis and correct folding of membrane proteins and metabolite transport 
[34, 35].  
1.2.1 Overview of the H.pylori infection process 
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Upon infection, H.pylori swims and escapes from the acidic lumen and quickly migrates 
to the epithelial surface where the pH is near neutral. H.pylori is highly motile, owning to 
their helical shape and flagella. Flagella motility is also required for the bacteria to 
penetrate through the physical barrier of the mucus layer [36]. Abundant surface 
ureases protects bacteria from local acid [34] and chemotaxis senses the pH gradient 
to guide bacteria swimming in the right direction [37, 38]. Furthermore, outer 
membrane proteins, such as BabA, SabA, or HopQ can help H.pylori to attach to the 
epithelial cells to avoid shedding from mucus turnover. Highly virulent H. pylori harbor 
the cag type IV secretion system (cag-T4SS), a needle-like apparatus protruding from 
the bacterial surface, which is able to inject the effector protein CagA (cytotoxin-
associated gene A) and peptidoglycan into host cells. After translocation, CagA can be 
phosphorylated by host cell kinases and then further interact with a set of eukaryotic 
signaling molecules to disrupt different signal transduction pathways, resulting in 
induction of a proinflammatory response and precancerous changes [39-42]. 
Therefore, CagA is considered a bacterial-derived carcinogen and a broad-spectrum 
intracellular toxin [43]. In addition, vacuolating cytotoxin A (VacA) is secreted to target 
epithelial cells and immune cells to facilitate bacterial growth, colonization, immune 
evasion and persistent infection [44]. 
The cag-T4SS has raised considerable attention during the past decades due to its role 
in the pathogenesis of Helicobacter-related diseases, including gastric inflammation 
and gastric cancer development [45]. The cag-T4SS is encoded by a 37 kb genomic 
region, the cag-pathogenicity island (cag-PAI), which encodes all the components of a 
T4SS, ranging from structural proteins, ATPases, coupling proteins to the only effector 
protein CagA and its secretion chaperone CagF [46]. The main feature of the Cag 
secretion system is to translocate CagA into host epithelial cells, which is associated 
with a high risk of developing gastric cancer [47]. The prototype T4SS, the VirB-T4SS 
in Agrobacterium tumefaciens, contains 11 structural components to form the 
apparatus (VirB1-VirB11) and a coupling protein VirD4 to recognize the substrate [48]. 
However, the H.pylori cag-T4SS encodes only some of the components sharing 
similarities with the VirB system and others are unique to the Cag system [46]. The 
1.2.2 H.pylori  cag-Type IV secretion system 
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cag-T4SS apparatus is a long channel-like structure consisting of an inner membrane 
complex, a core complex spanning inner and outer membrane, as well as an external 
pilus protruding outside of the bacteria. The detailed information about the architecture 
of the secretion system and its components is reviewed in several articles [46, 49, 50].  
The comprehensive molecular mechanisms of CagA translocation dynamics through the 
cag-T4SS apparatus are so far poorly understood. Before entering the translocation 
channel, CagF recognizes and binds specifically to CagA as a chaperone-like protein 
[51, 52], and the coupling protein Cagβ and its accessory protein CagZ form a 
complex to recognize the C-terminal secretion signal of CagA and to support CagA 
translocation [53-55]. After that, CagA is located at the pilus tip and further interacts 
with host factors to facilitate its uptake by host cells.  
Translocation of CagA into leukocytes leads to the proteolytic cleavage of native CagA 
protein into an N-terminal fragment (1-867 amino acid) and a C-terminal part (868-
1214 amino acid), indicating that there are 2 major domains of CagA [56]. The N-
terminal domain can be further divided into D1, D2 and D3/D4 domains according to its 
crystal structure determination. The C-terminal domain contains the EPIYA region, the 
CagF binding region and the 20 amino acid secretion signal [40, 57]. The C-terminal 
secretion signal is essential for CagA translocation, however, presence of the N-
terminal is critical as well, since the signal region alone cannot be translocated [52, 
58]. Furthermore, N-domain mutation and CagA immunoprecipitation revealed that 
CagF binding to both N-terminal and C-terminal regions of CagA serves as a quality 
control mechanism to guarantee the translocation of the integral CagA [52, 59].  
After translocation in gastric epithelial cells, CagA can bind to around 20 different host 
cell proteins in both phosphorylation-dependent and -independent manners to 
manipulate host cell signaling processes [43]. CagA can be phosphorylated in the 
EPIYA region by Src family kinases and C-Abl kinase at the host inner leaflet of the 
plasma membrane [60]. Phosphorylated CagA can bind to several host SH2 domain 
containing proteins. For example, phospho-CagA can bind and activate SHP2, a 
tyrosine phosphatase in the Ras-Erk mitogenic pathway [61]. SHP2 is considered as a 
proto-oncogenic phosphatase since mutations are detected in the gene encoding SHP2 
1.2.3 CagA and its cytotoxic and oncogenic effects in host cells  
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in leukemia and other cancers [62]. Especially, CagA from East Asian H.pylori strains 
can bind to SHP2 stronger than western CagA, indicating that East Asian H.pylori 
represents a higher risk for gastric cancer development. Moreover, activated SHP2 can 
further dephosphorylate and inhibit focal adhesion kinase, which regulates cell shape 
and motility, resulting in actin cytoskeleton rearrangement and abnormal cell shape, like 
the hummingbird phenotype in AGS cells [63, 64]. In addition, CagA can also bind to 
Crk adaptor proteins in a phosphorylation-dependent way, which is associated with 
disruption of E-cadherin/catenin–containing adherence junctions of gastric epithelium 
[65]. Furthermore, CagA has also been reported to interact with SH2 domains of Grb2, 
promoting proto-oncogenic Ras-Erk signaling in a different way [66]. Altogether, 
phosphorylated CagA can bind several SH2 domain-containing proteins in host cells to 
manipulate and perturb multiple signaling pathways as well as host cell functions. 
In addition, CagA can also subvert host cell functions in a phosphorylation-independent 
manner. CagA is reported to disrupt tight junctions of gastric epithelium by targeting 
PAR1 kinase, which leads to disorganization of epithelial apical-basal polarity and 
gastric mucosal architecture [67]. In addition, PAR1 also regulates microtubules, and 
inhibition of PAR1 by CagA perturbs segregation of sister chromatids in mitosis. As a 
result, CagA injected cells show chromosome instability and high risk of neoplastic 
transformation [68]. Furthermore, translocated CagA can hijack many other host 
signaling cascades important for cell proliferation, apoptosis and pro-inflammation 
[69-73]. In conclusion, the CagA toxin represents a sophisticated and versatile 
oncoprotein promoting host gastric carcinogenesis and tumor progression in many 
different ways.  
The cag-T4SS and CagA described above is one of the major virulence factors among 
H.pylori, other virulence factors include urease, chemotaxis, flagella, VacA, HtrA, 
different outer membrane proteins and others. VacA and some well-characterized outer 
membrane proteins are discussed in the following. 
The vacuolating cytotoxin VacA 
1.2.4 Other virulence factors of H.pylori 
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VacA is present in virtually all H.pylori strains. As a multifunctional secreted toxin, not 
only can VacA produce large intracellular vesicles after internalization (also known as 
vacuoles), but also contributes to bacterial pathogenesis in diverse ways. VacA can 
bind to T cells to inhibit T cell activation and proliferation for the sake of immune 
suppression and persistent colonization [74, 75]. Moreover, it can target mitochondria 
in epithelial cells to induce apoptosis, resulting in accelerated turnover to prevent cancer 
formation and tissue damage, and thus avoid immune cell recruitment [76].  
Furthermore, VacA can increase permeability of epithelial monolayers to get access to 
nutrients like iron, sugars and amino acids, although the mechanisms are not yet clear 
[77]. Most importantly, CagA and VacA can work together in a coordinate fashion, 
sometimes against each other and sometimes cooperate, to facilitate colonization, 
bacterial growth, and virulence [76, 78-80].  
Outer membrane proteins (OMPs) 
H.pylori contains five major outer membrane protein (OMP) families, which include 
more than 30 paralogous genes. However, only a few of them are well-characterized, 
most of the members remain uncharacterized [81]. OMPs mainly function as adhesins 
to facilitate initial colonization by attaching to epithelial cell surface to prevent 
mechanical clearance, especially when the gastric environment is dynamic and under 
conditions of peristaltic movement and secretion of gastric juices [82]. In addition, 
H.pylori adherence plays an important role in persistent infection and chronic 
inflammation, since it is highly unlikely that serious diseases like gastritis, gastric or 
duodenal ulcers, and MALT lymphoma can develop without adhesin-host interactions. 
Importantly, outer membrane proteins are regulated by several mechanisms such as 
point mutations in the coding region, phase variation, gene conversion, slipped strand 
mispairing (SSM), or gene duplication [81]. These regulations are beneficial for H.pylori 
survival by facilitating adaptation to the changing host environment and escaping host 
immune systems. 
Outer membrane protein BabA  
BabA (Blood group Antigen Binding adhesin) was the first identified outer membrane 
protein adhesin [83, 84]. BabA can bind specifically to fucosylated ABO blood group 
antigens and Lewis b antigens which are abundantly expressed in gastrointestinal 
epithelium [85, 86]. The interaction of the adhesin BabA and host Lewis b was shown 
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related to T4SS function and T4SS-induced effects in host cells. Ishijima et al. showed 
that the H.pylori wildtype strain ATCC 43504, but not its isogenic babA deletion mutant 
induced significantly increased IL-8 and a stronger CagA phosphorylation in Lewis b 
stably transfected Martin Dearby kidney cells (MDCK) cells. These in vitro data were 
confirmed in vivo in the Mongolian gerbil animal model by demonstrating that BabA was 
important for inducing enhanced IL-8 and chemokine (C-X-C motif) ligand 1 (CXCL1) 
[87]. In addition, BabA was described to co-localize with gastric mucin MUC5AC to 
promote damage to the gastric mucous gel [88]. Moreover, H.pylori can induce host 
DNA double strand breaks (DSBs) upon close contact with host cells, and this effect 
was shown to be BabA-dependent [89], suggesting BabA has carcinogenic potential, 
since constant repair of DSBs could highly enhance the probability of mutagenic events 
and genetic instability which in turn increase the cancer rate [13]. 
Outer membrane protein SabA 
SabA expression is related to development of gastric atrophy, intestinal metaplasia and 
gastric cancer [90]. Healthy gastric mucosa expresses nonsialylated antigens, 
however, H.pylori infection induces gastric inflammation and gastric adenocarcinoma 
and presents a low level of nonsialylated Lewis b antigens, but upregulated sialyl-
dimeric-Lewis x antigens and sialyl-dimeric–Lewis a antigens (sLex and sLea, 
respectively). H.pylori outer membrane protein SabA was shown to bind sLex and sLea 
and mediates bacterial adherence to inflamed tissue by mimicking selectin  [91].  
Marcos et al. demonstrated that highly virulent H.pylori strains containing cag 
pathogenicity island could manipulate expression of sLex by modulating host glycan 
biosynthesis, especially by inducing overexpression of a GlcNAc transferase (β3GnT5), 
to upregulate sLex expression and by enhancing SabA-mediated adherence [92]. 
Moreover, β3GnT5 induction is CagA- and CagE-dependent [92]. In this way, H.pylori 
expand their adherence ability by binding to both healthy tissue (BabA mediated) in the 
initial stage of infection and inflamed  gastric mucosa (SabA mediated) in late stage. 
Therefore SabA contributes to H.pylori virulence and chronic inflammation [93].  
Outer membrane protein HopQ 
HopQ belongs to the hop family of outer membrane proteins and the hopQ locus 
exhibits genetic diversity. There are two alleles in the locus: allele type I and allele type 
II. Type I and type II alleles show around 80% identity in nucleotide sequences and 
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around 70% identity  in amino acid sequences [94]. Moreover, Type I hopQ is usually 
found in the strains harboring the cag-PAI, but in some strains, both types are present 
at the same time [94]. Falkow and colleagues also reported that HopQ shows “co-
inheritance” with the cag island, which suggests that HopQ might contribute to the 
virulence of H. pylori [95]. Indeed, HopQ was recently identified as a virulence factor by 
Meyer and colleagues using a large transposon-based mutant library of H. pylori strain 
G27 to determine essential factors affecting nuclear translocation of the NFkB subunit 
P65 in AGS cells [96, 97]. These data were confirmed in strain P12. An isogenic hopQ 
deletion mutant exhibited significantly reduced NFkB translocation, IL-8 secretion, CagA 
phosphorylation and “hummingbird” cell shape formation in AGS cells. Taken together, 
these data suggest that HopQ is an essential accessory non-cag-PAI factor for T4SS 
function [96].  
Other outer membrane proteins 
Other outer membrane proteins are found to contribute to the H.pylori virulence as well. 
For example, AlpA and AlpB, two proteins that shared homology in their gene 
sequences, are involved in adherence. Deletion of these two genes resulted in reduced 
induction of IL-8 upon east Asian H.pylori strains infecting gastric epithelial cell lines 
[98]. Moreover, OipA, an OMP encoded by the hopH gene, also showed an assistant 
role in T4SS dependent IL-8 induction besides the adherence ability [99], and the 
presence of OipA is associated with enhanced neutrophil infiltration, gastric 
inflammation and cancer [100]. However, the host receptor for OipA has not been 
discovered yet. As we gain insight into the sophisticated outer membrane proteins, 
some questions are waiting to be answered. For examples, do these outer membrane 
proteins work sequentially or coordinately? Which adhesins are associated with or even 
essential to cag-T4SS function? How do adhesins and the cag-T4SS work together? 
Are adhesins and cag-T4SS components co-regulated?  
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1.3 Integrins as receptors exploited by pathogens 
integrins are transmembrane receptors with long extracellular domains and short 
cytoplasmic tails, and they can bind to different extracellular matrix (ECM) ligands like 
collagens, laminins or RGD motif-containing proteins. Integrins are typically 
heterodimers with an α and a β subunit. In mammals, there are 18 α subunits and 8 β 
subunits which assemble into 24 distinct integrins (Figure 1.2). Among them, integrin 
α6β4, αvβ5, αvβ6 and several β1 integrins (α1β1, α2β1, α3β1, α5β1, α6β1 and α9β1) 
are expressed on epithelial cells [101, 102]. Ligation of integrins to their ligands can 
trigger divergent signal transduction events known as “outside-in” signaling [103, 104]. 
However, integrins are also capable of "inside-out" signaling in ways that intracellular 
talin or kindlin binds to the cytoplasmic domain of integrins to further promote 
extracellular ligand binding [105, 106]. Through bidirectional signaling, integrins are 
involved in various cellular processes like cell survival and proliferation, homeostasis, 
cell motility, leukocyte trafficing and cancer progression [107-109]. In addition, 
integrins have either extended or bent conformations, indicating activated and 
inactivated status, respectively [103]. Of note, integrins are not constitutively active, 
and they are often kept in the inactive state which is important for their biological 
function [103, 110].  
 
 
Figure 1.2 The mammalian 
integrin receptor family and their 
ligands (modified from Hynes, 
2002). The figure illustrates 
integrin subunits αβ association 
and their ligands.  
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Meanwhile, integrins are recognized as the favored receptors of different viruses and 
bacteria for their adhesion, invasion or cellular entry [111-116]. Many pathogens can 
engage integrins directly or indirectly, not only to get access to their favored cells and 
tissues, but also to interfere with integrin linked signaling pathways and cellular 
functions to facilitate their surviving and virulence.  For instance, many pathogens can 
directly bind to integrin with high affinity or bind to ECM ligands to facilitate adherence 
and/or invasion like Yersinia pseudotuberculosis [117], Yersina enterocolitica [118], 
Staphylococcus aureus [119], Streptococcus pyogenes [120] , Leptospira interrogans 
[121], Campylobacter jejuni [122] , etc. Some pathogens can utilize integrin to deliver 
their virulence factor into host cells and further alter host cell functions like H.pylori. 
Although host epithelium have developed exfoliation as a host defense mechanism to 
restraint bacteria colonization, some bacteria establish strategies to slow down the turn 
over rate by increasing the integrin mediated cell adhesion to extracellular matrix to 
counteract the detachment of infected cells. For example, Neisseria gonorrhoeeae and 
Haemophilus influenzae can bind to CEACAMs and thus trigger endoglin (CD105) 
upregulation [123, 124]. Upregulated CD105 can change focal adhesion conformation 
and stimulate integrin β1 inside out signaling and therefore promote enhanced binding 
of integrin β1 and extracellular matrix [125]. On the contrary, some pathogens 
accelerate shedding of epithelial cells to get access to deeper tissues. For example, the 
uropathogenic E.coli (UPEC) produces a pore forming toxin for insertion into epithelial 
cell membranes. The toxin can degrade focal adhesion components paxillin and 
therefore disrupt cell-matrix adhesion [126]. Taken together, it is a common strategy 
for many pathogens to target integrins in order to break epithelial barriers, disrupt host 
first line of defense and alter integrin mediated cellular functions for their own 
advantages.  
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1.4 Helicobacter pylori host-pathogen interactions 
For many years the interaction of the cag-T4SS with the host cell membrane was not 
fully understood. From 2007 to 2010, researchers proposed different interaction models 
of CagA and/or T4SS with three diverse host cell receptors, including host cell integrin 
β1, host membrane phosphatidylserine and host membrane cholesterol.  
The first model was proposed in 2007, when Backert and colleagues first identified that 
host cell integrin β1 is exploited by H.pylori as host receptor for CagA translocation 
[127]. The first line of surmise came from the observation of co-localization of 
phosphorylated CagA (CagA-PY) and focal adhesion kinase (FAK) or vinculin at the 
focal adhesions, which led to the hypothesis that integrin β1 was involved in CagA 
translocation as the receptor. Indeed, more experiments supported this hypothesis: 
CagA phosphorylation was blocked in vitro by integrin β1 specific antibodies and a 
bacterial integrin β1 binding protein, Yersinia invasin InvA [127]. Furthermore, CagA 
phosphorylation was not observed in the integrin β1 knockout mouse fibroblast cell line 
GD25 upon H.pylori infection, but was restored in integrin β1 stable transfected GD25 
cells [127]. In addition, the RGD motif-containing CagL, a structural protein located in 
the pili of the T4SS, was verified as the binding partner of integrin β1. The RGD motif is 
the classical domain present in many extracellular matrix proteins, which can be 
recognized and bound by integrin β1. However, mutated CagL (with RGD changed into 
RAG motif) did not support CagA phosphorylation [127]. Therefore it was strongly 
suggested that the T4SS pili-associated protein CagL directly interacts with the host cell 
surface protein integrin β1 to trigger CagA translocation in an RGD dependent manner. 
However, an independent study by our group confirmed that H.pylori utilize integrin β1 
as the receptor, but in an RGD-independent fashion [128]. Firstly, interaction of CagL 
and integrin β1 could not be detected in either a Yeast Two Hybrid (YTH) screen,or in 
pull down assays. Secondly, either CagA phosphorylation efficiency or Interleukin-8 (IL-
8) induction was not impaired when RGD motif was completely removed from CagL 
protein upon H. pylori infection. Instead, T4SS components CagY, CagI and CagA itself 
were identified to interact with host cell integrin β1 in vitro, as proven by YTH and pull-
1.4.1 Interaction of the T4SS and host cell receptors in CagA translocation 
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down assays. However, integrin β1 ligands fibronectin, invasin and RGD peptide failed 
to block or reduce CagA phosphorylation. Moreover, eight out of nine different 
monoclonal antibodies which target different epitopes of integrin β1 could not abolish 
CagA phosphorylation with the exception of 9EG7, an antibody binding to EGF domain 
of integrin β1 and therefore locking integrin β1 in the extended conformation, 
accomplished to block. These results have led to the conclusion that the interaction of 
the cag-T4SS and host cell integrin β1 was not like the known binding mode of classic 
ligand/integrin interaction. Instead, the T4SS was proposed to bind to the extended 
conformation of integrin β1 to further force integrin to the bent conformation by 
unknown mechanisms. As a result, the T4SS pilus was pulled physically closer to the 
host cell to facilitate CagA translocation. However, the authors claimed that this 
outcome did not exclude the possibility that other co-receptors necessary for CagA 
phosphorylation were blocked by 9EG7. 
In 2008, Lai and colleagues showed that host cell membrane cholesterol is exploited by 
the H. pylori T4SS for CagA translocation [129], an observation which was inspired by 
the previous finding that host cholesterol is important for H. pylori virulence. 
Interestingly, H.pylori cholesterol-α-glucosyltransferase (CapJ) is responsible to exploit 
host cell cholesterol for subsequent glucosylation in order to promote immune evasion 
by escaping phagocytosis and inhibiting T-cell effects [130]. This discovery led them 
to propose that host cholesterol is utilized by H. pylori as the receptor for CagA 
translocation, which was supported by following evidences. First, host cell cholesterol 
depletion by methyl-β-cyclodextrin (MβCD) could significantly reduce CagA 
phosphorylation and IL-8 induction, as well as CagA-induced hummingbird phenotype 
[129]. In addition, H. pylori 26695 isogenic capJ deletion mutant led to drastically 
reduced CagA phosphorylation and CagA associated signaling pathways. Therefore, the 
authors proposed that H. pylori CapJ could convert host cholesterol into its cell wall 
components cholesteryl glucosides (CG). CG could further promote lipid rafts 
associated components clustering at the infection site, which might influence host 
membrane mobility and dynamics. Altered membrane architecture could be recognized 
by CG and thus trigger T4SS assembly and secretion function. 
In 2010, Hatakeyama and colleagues proposed a different CagA translocation 
mechanism. They showed that T4SS tip located CagA can directly interact with host 
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phosphatidylserine (PS) to mediate CagA internalization [131]. PS is an important 
phospholipid membrane component which constitutes about 10% of the total cell lipid 
content [132, 133]. PS is usually located in the inner leaflet of the cell membrane 
facing the cytosol [134]. If a cell undergoes apoptosis, the PS is flipped to the outside 
of the cell and is recognized by macrophages for phagocytosis of the cell [135]. 
However, in some non-apoptosis cases, PS can be aberrantly externalized by some 
pathogens like Chlamydia [136], Herpes simplex virus 1 (HSV-1) [137], vaccinia virus 
[138], hepatitis C virus [139] , pichinde virus [140] and others, to induce host cell 
apoptosis or to facilitate microbe internalization. H. pylori seems to trigger PS 
externalization upon infection with the similar motivation like other pathogens. Indeed, 
several facts supported their perspective: (i) CagA translocation was partially blocked by 
annexin V and PS specific antibodies. (ii) Recombinant CagA could bind PS in vitro and 
a classical PS binding motif KXnRXR was found to be present in the central region of 
CagA and is conserved throughout different H.pylori strains [131]. (iii) Mutated CagA-
R619/621A within the motif could not be translocated upon infection, suggesting CagA-
PS interaction is essential for CagA translocation. Although the exact mechanism of 
PS-bound CagA internalization into host cells was unclear, the author proposed that H. 
pylori infection could trigger temporary externalization of PS without actually inducing 
apoptosis to enable bacterial surface exposed CagA binding. Subsequently, CagA-
bound PS could flip back to the inside of cells with an unknown mechanism, and inner 
membrane PS-tethering CagA could further interact with PAR1 in polarized MDCK cells 
to disrupt tight junctions and cell polarity [67, 131].    
The aforementioned studies and data suggested there highlight at least three host cell 
factors involved in H.pylori type IV secretion. These researches have inspired us with 
comprehensive and insightful perspectives to the molecular mechanisms of type IV 
secretion and CagA translocation in the context of host-pathogen interaction.  
However, a lot of questions did also arise accordingly. For example, how does the 
CagL-integrin β1 interaction possibly contribute to the CagA transport across the host 
membrane? If CagY, CagI and CagA all bind to integrin β1, why did none of the tested 
integrin antibodies or integrin ligands block CagA translocation except one antibody, 
9EG7? What is the molecular mechanism underlying the internalization of CagA-bound 
PS? Since cholesterol depletion can lead to many side effects, what is the real reason 
for the CagA translocation blocking outcome by cholesterol depletion? Is there 
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cooperation between three reported host factors during CagA translocation? Taken 
together, the H. pylori CagA translocation mechanism is more complicated than 
originally proposed and H. pylori may use more host factors as receptors and might as 
well use backup receptors. Therefore, future studies need to investigate thoroughly to 
reveal the molecular mechanisms of H.pylori Type IV secretion. 
It is worth noting that our group has recently proven that host epithelial cell surface 
carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) are exploited by 
HopQ as receptors[141, 142]. CEACAMs belong to the IgCAMs (immunoglobulin 
superfamily of cell adhesion molecules) and are cell surface glycoproteins expressed in 
normal and malignant tissues mediating cell-cell adhesion and other important cellular 
processes including T cell proliferation, insulin homeostasis, neovascularization, 
apoptosis, cancer progression and metastasis. [143-145]. A lot of pathogens are 
reported to use CEACAMs as receptors for adhesion or invasion [111, 112, 123, 146-
149]. Our group has identified that host CEACAMs are exploited by HopQ for adhesion 
and CagA translocation, as indicated by the following observations. First, H.pylori can 
specifically bind to soluble GFP fusion proteins of the N-terminal domain of CEACAM1 
and CEACAM5, as shown by pull-down assays. Second, HopQ was identified as a 
binding partner of CEACAMs since an isogenic hopQ deletion mutant of strain P12 lost 
the binding ability in the pull-down assays. Third, HopQ-CEACAM interaction correlated 
with CagA translocation, as illustrated by the facts that those cell lines which allow 
CagA translocation did express CEACAMs on the surface (including AGS, KatoIII and 
MKN45), whereas cell lines non-permissive for CagA translocation only produced little 
or no CEACAMs (including MKN28, HeLa and HEK293). Significantly, HEK293 cells 
could become permissive for CagA translocation when CEACAM1 or CEACAM5 was 
stably transfected. Fourth, co-localization of H.pylori and CEACAM5 was detected in 
gastric biopsy isolates from H.pylori infected patients via microscopy studies[141, 
142]. These various findings showed conclusively that the HopQ-CEACAM interaction is 
essential for cag-T4SS function and reveal a distinct CagA translocation mechanism. 
1.4.2 Interaction of H.pylori outer membrane protein HopQ and host cell 
receptor CEACAMs -- Contribution of non-T4SS factors in CagA 
translocation 
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1.5 Aim of my study 
H.pylori host-pathogen interaction has raised considerable attention because of its role 
in pathogenesis. Particularly, understanding the molecular mechanism of CagA 
translocation holds promise in providing new insights and therapeutic target candidates 
for treating H.pylori induced gastric diseases, especially gastric cancer.  
Previous studies have confirmed that H.pylori exploits host cell integrin β1 for CagA 
translocation, which has been summarized in detail in the introduction section 1.4.  
However, several outcomes were difficult to understand or interpret. For example, it was 
shown that CagL can bind host cell integrin β1 to facilitate CagA translocation in a 
RGD-dependent manner. Whereas conflicting results were obtained by our group 
suggesting that the RGD motif is not necessary for CagA translocation. Moreover, our 
group has proven that several T4SS components can bind to integrin β1 to facilitate 
CagA translocation, but when the authors were trying to block CagA translocation with 
many different integrin β1 ligands, binding proteins or specific antibodies targeting 
different epitopes, none of them could abolish CagA translocation except for one of the 
antibodies (9EG7).  
These discrepancies led us to ask more questions. For example, is integrin β1 alone 
sufficient for CagA translocation? Since integrin αvβ3 showed high affinity for CagA 
binding, as revealed by surface plasmon resonance, is it possible that integrin αvβ3 can 
function as the receptor for CagA translocation as well? Are there other host cell 
integrins involved in this process? To answer these questions, my project mainly 
focused on the systematic generation of single to multiple integrin depletion gastric 
epithelial cell lines, and the subsequent evaluation of the CagA translocation efficiency 
in these integrin-depletion cell lines upon H.pylori infection. In this way, the study 
attempted to identify potential other host cell integrins which are exploited by H.pylori 
for CagA translocation. 
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2 Results 
2.1 Gene targeting of different integrins with the CRISPR-Cas system 
In order to study the role of different host cell integrins in H.pylori CagA translocation, 
generation of different integrin-depletion cell lines is the first step. AGS and KatoIII cell 
lines are generally used for the evaluation of CagA translocation efficiency, since both 
cell lines were derived from gastric epithelial cells and are standard cell lines to study 
H.pylori pathogenesis in vitro. Therefore, integrin-depletion AGS and KatoIII cell lines 
were planed to establish. 
The integrin receptor family is composed of 24 distinct integrins which are heterodimers 
consisting of different α and β subunits distributed in different cell types and tissues. 
Figure 2.1 A shows the αβ association of integrins which are expressed on non-
leukocyte and non-platelet cell surfaces. Among them, six β1 integrins (α1β1, α2β1, α3
β1, α5β1, α6β1 and α9β1), two αv integrins (αvβ5 and αvβ6) and the integrin α6β4 are 
shown to be epithelial-specific [102, 150-153].   
Gene targeting with the CRISPR-Cas9 system in the absence of the repair template can 
lead to gene knockout. Furthermore, gene targeting in either subunit of the integrin 
heterodimer can eventually result in depletion of surface expression of targeted integrin, 
since it was shown that a defect in either subunit prevented intracellular αβ association 
and therefore abolished a functional integrin heterodimer surface expression [154, 
155]. Thus, we sought to finally target three important genes in parallel, the integrin β1 
gene, the integrin αv gene and the integrin β4 gene. This should generate the integrin β1 
depletion cell lines (AGS and KatoIII cell lines) without surface expression of all 12 
potential β1 containing integrins, including 6 epithelial-specific β1 integrins, the integrin 
αv knockout cell lines without surface expression of all 4 potential αv containing 
integrins, including 2 epithelial-specific ones, as well as the integrin β4 knockout cell 
lines without expression of the integrin α6β4. Furthermore, by targeting different 
combinations of two of the aforementioned genes at the same time, cell lines deprived 
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of even more integrins should be generated. Ultimately, by targeting three genes at the 
same time, cell lines without any integrin surface expression should be generated.   
To first have an overview of integrin expression on the surface of AGS and Kato III, the 
cells were stained with different integrin antibodies and the integrin expression was 
profiled by flow cytometry. Therefore, integrin β1 antibody, integrin αv antibody, integrin 
β4 antibody and a few others were used for the profiling. Moreover, goat-anti mouse 
and goat-anti rat secondary antibodies were used for the negative controls, to exclude 
false positive results.  
Indeed, AGS and KatoIII cells were found to express β1 integrins (including α2β1, α3β1 
and possibly others), αv integrin(s) and the β4 integrin (α6β4) on their surfaces with 
varying expression levels (Figure2.1 B and C). 
 
Figure2.1 The integrin expression profiling in AGS and KatoIII cells. A, The αβ association of non-
leukocyte and non-platelet integrins. B, Integrin profiling in wildtype AGS cells using different 
integrin antibodies (n=3). C, Integrin profiling in wildtype KatoIII cells using different integrin 
antibodies (n=3). All values in B and C were indicated as standard errors of the mean (±SEM) 
from three independent experiments. ITGA, integrin α; ITGB, integrin β. Integrin antibodies were 
used as following: integrin α1 antibody (clone FB12), integrin α2 antibody (clone P1E6), integrin 
α3 antibody (clone P1B5), integrin α4 antibody (clone P1H4), integrin α5 antibody (clone P1D6), 
integrinβ1 antibody (AIIB2), integrin αv antibody (clone P2W7), integrinβ4 antibody (clone 439-
9B). 
2.1.1 Integrin profiling in AGS and KatoIII cells 
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2.1.2.1 Design of paired 20-nt guide sequences for targeting the integrin β1 gene 
with the double-nicking strategy 
In order to obtain integrin β1 depletion cell lines without undesired off-target 
mutagenesis, the double nicking strategy was applied. It was reported that the Cas9 
nuclease can tolerate certain mismatches in the base-pairing between guide RNAs and 
their target locus, and therefore exhibits off-target potential [6]. Cas9 nucleases 
contain two catalytic domains: HNH and RuvC; each of them cut one strand of the 
target DNA. It was shown that an aspartate to alanine (D10A) mutation in the RuvC 
domain renders the Cas9 nuclease to a Cas9 nickase [156]. Paired sgRNAs can lead 
Cas9 nickase making single-stranded nicks on both strands of the target DNA 
simultaneously. As a result, the double strand breaks (DSBs) are generated from double 
nicking and therefore facilitate the target gene knockout, as illustrated in Figure 2.2. Of 
note, as nicks can be repaired scarlessly by the high-fidelity BER pathway [157], 
double strand breaks only occur if a pair of sgRNAs target opposite strands of a target 
locus within a defined space (0-100 bp offset). In this way, the double nicking strategy 
requires 2 targets to introduce DSBs, which doubles the base-pairing length between 
sgRNAs and their target locus. As a result, it effectively minimizes off-target activity and 
greatly enhances the genome editing specificity. 
For design of paired short guide RNAs (sgRNAs) targeting integrin β1 (ITGB1) gene, an 
online CRISPR design tool (http://tools.genome-engineering.org) was used for optimal 
sgRNA analysis and identification. To begin with, the genomic DNA sequence of the 
ITGB1 gene was downloaded from National Center for Biotechnology Information 
(NCBI) (http://www.ncbi.nlm.nih.gov/nuccore/NG_029012.1?from=5001&to=63048& 
report=genbank). Subsequently, the genomic fragments of 23-250 bp from exon 1 to 
exon 5 of the integrin β1 gene were loaded into the design tool one after another for 
screening optimum targets.  
2.1.2 Integrin β1 gene targeting with the CRISPR-Cas9 system 
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Figure 2.2 Gene targeting by the double nicking strategy. Double nicking strategy requires paired 
sgRNAs at the same time guiding Cas9 D10A nickase. Cas9 nickases mediates nicks 3 bp 
upstream the PAMs on the opposite strand of the targets (see illustration: target DNA loci: 
highlighted in blue; PAMs: highlighted in orange; nickase cleavage sites on both DNA strand: 
orange triangles). To promote efficient double nicking, the pair of sgRNAs should be designed 
that 5’ overhangs are generated rather than 3’ overhangs. The DSBs from double nicking are 
repaired by non-homologous end joining (NHEJ) producing indel formations, frame shifts and 
premature stop codons, which result in gene knockout. 
After screening and analysis in silico, all the possible sgRNA target sites were identified, 
ranked and scored by the design tool according to the predicted efficiency, number of 
off-target sites and secondary structures. There were 5 pairs of sgRNAs available in the 
integrin β1 gene exon 5, and the detailed information of each pair was shown in the 
design tool when the interested pair was clicked. As illustrated in Figure 2.3, the scores, 
sequences, as well as the number of offtargets and genic offtargets (offtargets located 
in gene-coding region) were shown for the selected top sgRNA pair on the list. The 
sgRNA A (guide A) and sgRNA B (guide B) were appropriately spaced and oriented in 
integrin β1 gene exon 5 as illustrated in Figure 2.4 A and named as ZQ80 and ZQ82, 
respectively.  
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Figure 2.3 Recommended paired sgRNAs targeting the ITGB1 gene by the online CRISPR design 
tool. When the top pair with the highest score was chosen, the design tool showed the 
sequences, scores, the 3’-PAM sequences, number of offtargets and genic offtargets of each 
sgRNA. Guide A alone exhibited 205 off-targets including 15 genic offtargets and guide B 155 
off-targets with 6 genic offtargets. Whereas guide A and B pair presented no offtarget. 
2.1.2.2  CRISPR plasmids construction 
In order to clone designed sgRNAs into CRISPR vectors to obtain functional CRISPR 
constructs, designed paired guides by the online tool were optimized. An additional 
guanine (G highlighted in yellow rectangle) was added 5’ immediately before the guide 
sequences (in blue) for the preference of the U6 transcription. And an overhang (CACC 
in black) was added for the ligation into the BbsI sites in the CRISPR vector pSpCas9 
nickase (BB)-2A-Puro (PX462, Addgene ID: 48141). Subsequently, the complementary 
oligos of guide A and guide B were designed accordingly and all the oligos needed for 
the ITGB1 gene targeting were ordered commercially as listed in Table 2.1.  
Table 2.1 sequences of paired sgRNAs designed for targeting ITGB1 gene 
sgRNA 
targeting 
ITGB1 
gene 
Guide A 
top oligo (ZQ80) 5’- CACCGAGTTCTGTTCACTTGTGCAA – 3’ 
bottom oligo (ZQ81) 5’- AAACTTGCACAAGTGAACAGAACTC – 3’ 
Guide B 
top oligo (ZQ82) 5’- CACCGGTGCTCAGTCTTACTAATAA – 3’ 
bottom oligo (ZQ83) 5’- AAACTTATTAGTAAGACTGAGCACC – 3’ 
 
The complementary oligo pairs were annealed before cloning into the vector. The 
cloning scheme for PX462-8081 (sgRNA guide A expressing CRISPR construct) and 
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PX462-8283 (sgRNA guide B expressing CRISPR construct) is illustrated as in Figure 
2.4 B.  
 
Figure 2.4 The sgRNA locations in integrin β1 gene and the generation of corresponding plasmids. 
(A) For Streptococcus pyogenes Cas9 nickase, 20bp targets (highlighted in blue) were 
immediately followed at their 3’ ends by the 5’-NGG PAM (protospacer adjacent motif). The 
sgRNA pairs located on both strands of target DNA and were spaced with a 25 bp gap. Two 
appropriate targets in exon 5 of integrin β1 gene were selected in silico by using the online 
CRISPR Design Tool (http://tools.genome-engineering.org). (B) Cloning scheme of the CRISPR 
plasmids. Top and bottom oligos were commercially ordered and anealed before ligation. 
Restrictive digestion of vector pSpCas9nickase(BB) with BbsI allowed direct insertion of anealed 
oligos. Importantly, an extra G-C base pair (in gray) was appended at the 5’ end of the guide 
sequence for the transcription preference of the U6 RNA polymerase III promoter. 
Sequencing of each construct was started from the U6 promoter in both vectors by 
using the U6-Fwd primer (ZQ66, section 4.1.3). Sequencing results showed that both 
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constructs, PX462-8081 (clone 1) and PX462-8283 (clone1), had the correct insertion 
of guide sequences sgRNA 8081 and 8283 in the vector PX462 (Figure 2.5). 
A 
 
Figure 2.5 sequence 
verification of CRISPR 
construct targeting 
ITGB1 gene. A, 
Sequencing 
verification of PX462-
8081 (clone1). 
Designed sgRNA 
ZQ8081 was correctly 
inserted in the vector 
PX462. B, Sequencing 
verification of PX462-
8283 (clone1). 
Designed sgRNA 
ZQ8283 was correctly 
inserted in the vector 
PX462. 
B 
Design of sgRNAs for targeting human integrin αv (ITGAv) gene and the CRISPR  
plasmids construction were similar as in section 2.1.2, except that integrin αv genomic 
DNA sequence were downloaded from NCBI  (http://www.ncbi.nlm.nih.gov/nuccore/NG 
_029012.1?from=5001&to=63048&report=genbank). A pair of sgRNA guides which 
located in the exon 4 of the integrin αv gene was chosen among the recommendations 
from the online CRISPR design tool according to the ranking and scoring, and the 
sequences and orientation of the guides are illustrated in Figure 2.6.  
2.1.3 Integrin v targeting with the CRISPR-Cas9 system 
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Figure 2.6 The oriantation and location of the sgRNA pair selected for Integrin v gene targeting. 
For S.pyogenes Cas9 nickase, 20bp sgRNA pairs (hignlighted in blue) were immediately followed 
at their 3’ ends by the 5’-NGG PAM (protospacer adjacent motif). The sgRNA pairs located on 
both strands of target DNA and were spaced with a 9 bp gap. Two appropriate targets in exon 4 
of integrin v gene were recommended in silico by using the online CRISPR Design Tool 
(http://tools.genome-engineering.org). 
All the oligos designed for targeting the ITGAv gene are listed in Table 2.2. Furthermore, 
the construction of the CRISPR plasmid PX462-9596 and PX462-9798 targeting integrin 
v gene was similar as in section 2.1.2.2 and will not be repeated here. The sequencing 
results of the two constructs revealed correct insertion of designed sgRNAs in the 
CRISPR vector PX462 (data not shown). 
Table 2.2 Sequences of paired sgRNAs designed for targeting integrin v gene 
sgRNAs 
targeting 
ITGAv 
gene 
Guide 
A 
top oligo (ZQ95) 5’- CACCGCAGTTCTCCAATGGTACAAT – 3’ 
bottom oligo (ZQ96) 5’- AAACATTGTACCATTGGAGAACTGC – 3’ 
Guide 
B 
top oligo (ZQ97) 5’- CACCGAAACAGGAGCGAGAGCCTGT – 3’ 
bottom oligo (ZQ98) 5’- AAACACAGGCTCTCGCTCCTGTTTC – 3’ 
   
2.1.4 Integrin β4 targeting with the CRISPR-Cas9 system 
Procedures for designing the paired sgRNAs targeting integrin β4 (ITGB4) gene and the 
preparation of sgRNA constructs were similar as described in section 2.1.2 and 2.1.3. 
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However, the integrin β4 genomic DNA sequence was downloaded from NCBI (http:// 
www.ncbi.nlm.nih.gov/nuccore/NG_007372.1?from=5001&to=41384&report=genebank) 
and the selected paired sgRNAs were located in exon 6 (Figure 2.7).  
 
Figure 2.7 The oriantation and location of the sgRNA pair selected for Integrin β4 gene targeting. 
For S.pyogenes Cas9 nickase, 20bp sgRNA pairs (hignlighted in blue) were immediately followed 
at their 3’ ends by the 5’-NGG PAM (protospacer adjacent motif). The sgRNA pairs located on 
both strands of target DNA and were spaced with a 21 bp gap. Two appropriate targets in exon 
6 of the integrin β4 gene were recommended in silico by using the online CRISPR Design Tool 
(http://tools.genome-engineering.org). 
The paired sgRNAs designed for targeting integrin β4 (ITGB4) gene are listed in Table 
2.3, and the sequencing results of CRISPR constructs PX462-1&2 and PX462-3&4 
showed that sgRNAs were correctly inserted into the vector PX462 (data not shown). 
Table 2.3 sequences of paired sgRNAs designed for targeting ITGB4 gene 
sgRNAs 
targeting 
ITGB4 
gene 
Guide A 
top oligo (CU1) 5’ -CACCGAAATCCAATAGTGTAGTCGC-3’ 
bottom oligo (CU2) 5’ -AAACGCGACTACACTATTGGATTTC-3’ 
Guide B 
top oligo (CU3) 5’- CACCGGCGTCCCGCAGACGGACATG-3’ 
bottom oligo (CU4) 5’- AAACCATGTCCGTCTGCGGGACGCC-3’ 
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For generation of integrin-depletion AGS and KatoIII cell lines, verified CRISPR 
constructs targeting different integrin genes were transfected or cotransfected into AGS 
and KatoIII cells. Transfected cells went through several selection procedures in order to 
obtain the clonal deületion cell lines. Firstly, the transfected population was treated with 
puromycin so that the untransfected cells were killed since CRISPR constructs contain 
the puromycin resistance gene. Secondly, the surviving cells were stained with 
corresponding integrin antibodies for the negative selection by FACS sorting. Thridly, 
the sorted negative population was diluted by serial dilution to generate clonal cells. In 
the end, twelve clonal cell lines were obtained, including five integrin-depletion AGS cell 
lines and seven integrin-depletion KatoIII cell lines. All the depletion cell lines were 
established with the double nicking strategy by introducing paired CRISPR constructs 
targeting the respective integrin gene in target cell lines. All the constructs used for the 
cell line generation are listed in Table 2.4. In addition, all cell lines were generated by 
targeting wildtype AGS or KatoIII directly. However, ITGB1B4 KO AGS and ITGAvB1B4 
KO KatoIII cell lines were generated by targeting previously generated integrin-depletion 
cell lines (Table 2.4).  
All obtained integrin-depletion cell lines were verified by surface detection of different 
integrins using flow cytometry with corresponding antibodies. Compared to wildtype cell 
lines, each knockout cell line showed a complete depletion of the corresponding 
integrin(s) surface expression (Figure 2.8 - 2.9).  
 
 
 
 
 
 
 
 
2.1.5 Generation of single- and multiple-integrin depletion cell lines 
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Table 2.4 CRISPR constructs and targeted cell lines for the generation of integrin-
depletion AGS and KatoIII cell lines 
Integrin knockout cell lines 
Constructs used for 
transfection 
Target cell line 
ITGB1 KO AGS 
PX462-5859 
PX462-6061 
Wildtype AGS 
ITGB1 KO KatoIII Wildtype KatoIII 
ITGAv KO AGS PX462-9596 
PX462-9798 
Wildtype AGS 
ITGAv KO KatoIII Wildtype KatoIII 
ITGB4 KO AGS PX462-1&2 
PX462-3&4 
Wildtype AGS 
ITGB4 KO KatoIII Wildtype KatoIII 
ITGB1B4 KO AGS 
PX462-1&2 
PX462-3&4 
ITGB1 KO AGS 
ITGB1B4 KO KatoIII 
PX462-5859 
PX462-6061 
PX462-1&2 
PX462-3&4 
Wildtype KatoIII 
ITGAvB4 KO AGS 
PX462-9596 
PX462-9798 
PX462-1&2 
PX462-3&4 
Wildtype AGS 
ITGAvB4 KO KatoIII Wildtype KatoIII 
ITGAvB1 KO KatoIII 
PX462-5859 
PX462-6061 
PX462-9596 
PX462-9798 
Wildtype KatoIII 
ITGAvB1B4 KO KatoIII 
PX462-5859 
PX462-6061 
ITGAvB4 KO KatoIII 
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Figure 2.8 Verification of integrin expression on wildtype AGS and its five integrin-depletion cell 
lines (n=3). Integrin expression was determined showing FITC median from three independent 
flow cytometry experiments. FITC-A histograms are representatives of three experiments. As 
negative controls, cells were stained only with secondary antibody (Goat-anti mouse, Goat-anti 
rat). Comparing to wildtype AGS cells, all of the integrin-depletion cell lines showed the 
complete loss of the corresponding integrin expressions on their surfaces.  A, ITGB1 surface 
expression on wildtype AGS cells and ITGB1 KO AGS cells. B, ITGAv surface expression on 
wildtype AGS cells and ITGAv KO AGS cells. C, ITGB4 surface expression on wildtype AGS cells 
and ITGB4 KO AGS cells. D, ITGB1 and ITGB4 surface expression in wildtype AGS cells and 
ITGB1B4 KO AGS cells. E, ITGAv and ITGB4 surface expression in wildtype AGS cells and 
ITGAvB4 KO AGS cells. All values were indicated as average values including standard errors of 
the mean (±SEM). 
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all the integrin-depleted cell lines showed the complete depletion of the corresponding  integrin 
expression on their surface. A, ITGB1 surface expression in wildtype KatoIII cells and ITGB1 KO KatoIII 
cells. B, ITGAv surface expression in wildtype KatoIII cells and ITGAv KO KatoIII cells. C, ITGB4 surface 
expression in wildtype KatoIII cells and ITGB4 KO KatoIII cells. D, ITGAv and ITGB1 surface expression in 
wildtype KatoIII cells and ITGAvB1 KO KatoIII cells. E, ITGAv and ITGB4 surface expression in wildtype 
KatoIII cells and ITGAvB4 KO KatoIII cells. F, ITGB1 and ITGB4 surface expression in wildtype KatoIII cells 
and ITGB1B4 KO KatoIII cells. G, ITGAv, ITGB1 and ITGB4 surface expression in wildtype KatoIII cells and 
ITGAvB1B4 KO KatoIII cells. All values were indicated as average values including standard errors of the 
mean (±SEM).  
Figure 2.9 Verification of integrin 
expression on wildtype KatoIII and its 
seven integrin-depletion cell lines (n=3). 
Integrin expression was determined showing 
FITC median from three independent flow 
cytometry experiments. FITC-A histograms 
are representatives of three experiments. As 
negative controls, cells were stained only with 
secondary antibody (Goat-anti mouse, Goat-
anti rat). Comparing to wildtype KatoIII cells,  
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2.2 Quantification of CagA translocation in integrin-depletion cell 
lines by measuring TEM-1 β-lactamase activity 
In order to understand the role and the molecular basis of the interaction of T4SS and 
host cell integrins, the CagA translocation efficiency was evaluated in the generated 
integrin-depletion cell lines. The result should help to answer the question whether 
Integrin β1 alone is sufficient for CagA translocation, and whether it is possible that 
other integrins are involved in this process. 
Traditionally, by using the fact that CagA can be phosphorylated by host cell kinases 
when translocated into the host cells, CagA translocation efficiency is assessed by 
detecting a phosphorylated CagA band in H.pylori infected cells via western blot. 
However, the use of western blot as a quantification method is questioned [158], 
especially when the conclusions are dependent on subtle differences between the 
samples. 
Fortunately, a sensitive β-lactamase reporter system has recently been established in 
our lab to quantitatively examine H.pylori CagA translocation into host cells [52]. One 
of the major advantages about this system is that it can monitor and assess CagA 
translocation independently of its tyrosine phosphorylation and host cell kinase activity. 
β-lactamases (BLA) are enzymes produced by bacteria to facilitate resistance to β-
lactam antibiotics by breaking the β-lactam ring open through hydrolysis. The ability to 
use BLA as a fluorescence-based reporter gene was not realized until the development 
and synthesis of the fluorescent substrates CCF2-AM [159] and CCF4-AM, which are 
composed of two fluorescent dyes, 7-hydroxycoumarin-3-carboxamide and 
fluorescein, bridged by a cephalosporin moiety (Figure 2.10). CCF4 is relatively more 
soluble than CCF2 and thus has been preferred for some experiments. Neither BLA nor 
its intact or cleaved substrate is toxic to eukaryotic cells, therefore, it is possible to 
introduce the system in live cells or live animals. 
To apply the system for H.pylori in vitro infection experiments to measure CagA 
translocation, a TEM-1 β-lactamase was previously fused to the N-terminus of CagA 
from H.pylori strain P12 [52]. When host cells were infected by this modified H. pylori, 
the in frame protein fusion of TEM-1 β-lactamase and the CagA (TEM-CagA) was 
injected by the T4SS into host cells. Upon arrival of TEM-CagA, The fluorescent 
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substrate loaded into the host cells will be cleaved by TEM-1, thus resulting in 
disruption of Fluorescence Resonance Energy Transfer (FRET) of the substrate to 
convert the substrate fluorescence from green to blue (Figure 2.10). By measuring and 
calculating the ratio of blue to green fluorescence with either a plate reader or by flow 
cytometry, translocation of TEM-CagA can be evaluated quantitatively with high 
sensitivity. 
 
Figure 2.10 Illustration of the β-lactamase reporter system. The lipophilic and esterified 
(acetoxymethylated; AM) form of the substrate CCF2 or CCF4 (CCF2/4-AM) can enter 
eukaryotic cells with ease and readiness. Once CCF2/4-AM enters a cell, host esterases convert 
it into its negatively charged form (CCF2/4) which is maintained in the cytoplasm. In the 
absence of TEM-1, excitation of hydroxycoumarin at 409 nm exhibits FRET to fluorescein which 
generates green fluorescence (520 nm). In the presence of TEM-1, in this case when TEM-
CagA is injected into host cells by the T4SS upon infection, CCF2/4 is hydrolyzed and therefore 
FRET is disrupted, coumarin emits at 447nm and produces the green fluorescence. 
To investigate CagA translocation in different integrin-depletion AGS cell lines 
independent of its tyrosine phosphorylation and host kinase activity, the β-lactamase 
reporter system was applied by using H.pylori strains to infect different integrin-
depletion cell lines in vitro. The bacterial strains included P12[TEM-CagA], and its 
isogenic hopQ deletion mutant (P12ΔhopQ[TEM-CagA]). As mentioned in section 
2.2.1  Host cell integrin-independent CagA translocation in AGS cells  
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1.4.2, outer membrane protein HopQ can bind to host CEACAMs and the binding is 
essential for CagA translocation[141, 142]. Therefore the isogenic hopQ deletion 
mutant was used to disrupt the HopQ-CEACAM interaction, in order to evaluate CagA 
translocation efficiency when both host cell CEACAM and integrin receptors do not 
function properly. As negative controls, the isogenic cagI deletion mutant (P12Δ
cagI[TEM-CagA]) was used, since deletion of cagI results in a defect in the Type IV 
secretion system [160].  
 
Figure 2.11 Quantitative evaluation of TEM-CagA translocation into AGS and its five integrin- 
depletion cell lines (n=5). AGS and its five integrin-depletion cell lines were seeded in 96-well 
plates and infected with P12[TEM-CagA], its hopQ deletion mutant and its cagI deletion mutant 
at an MOI of 60. After 2.5h infection, substrate CCF4-AM was loaded in each cell line for 2 h. 
Green and blue fluorescence of each well were measured by a plate reader. Ratios of blue to 
green fluorescence of each sample were calculated and normalized to the mean of blue to green 
ratio of its negative controls. All values were indicated as standard errors of the mean (±SEM) 
from five independent experiments. The significance of differences was analyzed using One way 
ANOVA (n.s., non-significant). 
The blue to green fluorescence of each infection was measured by a plate reader and 
the ratio was calculated as an indicator for translocation efficiency. Surprisingly, as 
illustrated in Figure 2.11, all five different integrin-depletion cell lines showed 
comparable translocation efficiencies to the AGS wildtype cell line when infected with 
P12[TEM-CagA]. Moreover, all five integrin-depletion cell lines exhibited a similar level 
of translocation as AGS cells when infected with the P12ΔhopQ[TEM-CagA] strain, 
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which is strongly reduced in its capacity to translocate CagA. As expected, all cell lines 
showed a very low (background level) blue to green fluorescence ratio when infected 
with T4SS defective mutant P12ΔcagI[TEM-CagA]. The data presented here confirmed 
that the HopQ-CEACAM interaction is necessary for the CagA tanslocation. Moreover, it 
showed that single to multiple integrin depletion did not affect CagA tranlocation 
efficiency, suggesting a so-far unrecognizedl host cell integrin-independent CagA 
translocation into AGS cells. 
CagA translocation was quantified in seven different integrin-depletion KatoIII cell lines 
with the β-lactamase reporter system as well, and the blue and green fluorescence in 
each cell was measured by flow cytometry. After calculating of the blue-to-green ratio 
of each infection and the statistical analyzing from four independent experiments, the 
ITGAvB1 KO KatoIII cell line showed a significant reduction in CagA translocation when 
infected with P12[TEM-CagA], compared to wildtype KatoIII cells. However, when 
infected with P12ΔhopQ[TEM-CagA], all cell lines including wildtype KatoIII showed a 
slight shift from green to blue, indicating arrival of a small amount of TEM-CagA in the 
cells, which did not make a statistical difference. The type IV secretion defective 
negative controls (P12ΔcagI[TEM-CagA]) showed no shift or only a background shift 
(Figure 2.12). The data suggested that the HopQ-CEACAM interaction was the major 
contributor in the CagA translocation process in KatoIII cells. Except for the ITGAvB1 KO 
KatoIII cell line, other integrin-depletion cell lines exhibited host cell integrin-
independent CagA translocation. In addition, the ITGAvB1 KO KatoIII cell line showed a 
compromised CagA translocation efficiency, which was not observed in the ITGAvB1B4 
KO KatoIII cell line. The reasons for this discrepancy will be further investigated in 
section 2.4. 
2.2.2 Host cell integrin-independent CagA translocation in KatoIII cells 
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Figure 2.12 Quantitative evaluation of TEM-CagA translocation into KatoIII and its seven integrin-
depletion cell lines (n=4). KatoIII and its integrin-depletion cell lines were infected with P12[TEM-
CagA], its hopQ deletion mutant and its cagI deletion mutant with the MOI of 60 for 3h. 
Subsequently, substrate CCF4-AM was loaded into infected cells for 1.5h. A. Fluorescence of 
each cell was analyzed by flow cytometry in the AmCyan (green) and Pacific Blue (blue) 
channels. Different degrees of green-to-blue shifting indicated varying amount of TEM-CagA 
being translocated into cells. Plots are the representative of four independent experiments. B. 
After calculating the ratio of blue to green of each sample from four independent experiments, 
CagA translocation quantification was determined by normalizing the Blue/Green ratio to the 
mean of the respective negative controls. All values are shown as standard errors of the mean (
±SEM). The significance of differences was analyzed using One way ANOVA (**P<0.05). 
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2.3 Qualification of CagA translocation in integrin-depletion cell lines 
by detecting phosphorylated tyrosine (in collaboration with Katrin 
Gerrer) 
In order to exclude the possibility that the observed integrin-independent CagA 
translocation was caused by strain-specific effects of H.pylori strain P12, other strains 
with distant geographical origin were used to infect the ITGAvB1 KO and the ITGAvB1B4 
KO KatoIII cell lines. It is known that after translocation into host cells, CagA can be 
tyrosine-phosphorylated by host Src family kinases and C-Abl kinase at the host inner 
leaflet of the plasma membrane. Therefore, the traditional and classical way of CagA 
translocation qualification is the detection of tyrosine-phosphorylated CagA from 
infected cells.  
 
Figure 2.13 Qualification of CagA translocation in integrin-depletion cell lines by different H.pylori 
strains. KatoIII cells and the two integrin-depletion cell lines were infected with strain G27, 1-20A 
and TN2GF4 for 4 hours with an MOI of 60. Translocation of CagA was determined by detecting 
tyrosine-phosohorylated CagA with the antibody 4G10. n.inf.: non-infected control. 
H.pylori strain G27 was originally isolated from Europe, 1-20A from Africa and TN2GF4 
from East Asia. KatoIII cells infected with these H.pylori strains were used as the 
positive controls. As the negative controls, two integrin-depletion cell lines were left 
without infection. As indicated in Figure 2.13, a phosphorylated CagA band can be 
detected in each infected sample except the negative controls, as highlighted in the red 
box, indicating that all three different H.pylori stains had successfully translocated CagA 
into the two tested integrin-depletion cell lines, as well as into positive control cell line 
KatoIII. As the loading controls, the tubulin immunoblot demonstrates total cell lysates 
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loaded in the SDS gel, the RecA blot shows the amount of bacteria in the cell lysates 
and the CagA blot indicates the total CagA amount in the lysates. The sizes of the 
CagA bands as well as the phosphorylated CagA bands were slightly different, revealing 
that CagA from different strains has variable molecular weight.  
Thus, independent H.pylori strains showed CagA translocation in two representative 
integrin-depletion cell lines. In summary, these data suggest that the observed host cell 
integrin-independent CagA translocation is a common phenomenon among diverse 
H.pylori strains and is not a specific effect of strain P12.   
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2.4 Integrin and CEACAM profiling in integrin-depletion cell lines 
Since changes in the expressions of host receptors (integrins and CEACAMs) on the cell 
surface can alter the CagA translocation results, an integrin and CEACAM profiling in 
each integrin-depletion cell line was performed, in order to investigate whether 
depletion of integrin(s) can influence the expression levels of other receptors, such as 
the remaining integrins and the CEACAMs. 
To profile integrin expression on each integrin-depletion cell surface, integrin α1, 
integrin α2, integrin α3, integrin α4, integrin α5, integrin αv, integrin β1 and integrin β4 
expression was determined by flow cytometry using specific antibodies. In parallel, 
wildtype AGS and KatoIII cell lines were stained with the antibodies mentioned above as 
the positive controls. Furthermore, all cell lines were stained with secondary antibodies 
alone as the negative controls. As indicated in Figure 2.14 A, the remaining integrins 
expressed on the surface of each integrin-depletion AGS cell line exhibited similar 
expression levels as were found on wildtype AGS cells, and the statistical test (one way 
ANOVA) showed no significant deviation between each integrin-depletion cell line and 
AGS wildtype cell line.  
However, the situation was different in integrin-depletion KatoIII cell lines as indicated 
by the following observations. As compared to wildtype KatoIII, the ITGB1 KO KatoIII 
cell line showed a significant reduction in integrin αv (P<0.001) and integrin β4 
expression (P<0.001). The ITGAv as well as the ITGAvB4 KO KatoIII cell lines exhibited a 
significantly decreased integrin β4 expression (P<0.05) and (P<0.001), respectively. 
(Figure 2.14 B).  
In conclusion, the integrin depletion did not affect expression levels of remaining 
integrins in AGS cells. On the other hand, depletion of certain integrins in KatoIII cells 
led to a significantly decreased expression of some remaining integrins. However, these 
changes did not influence the CagA translocation outcome, which will be discussed in 
section 3.3. 
2.4.1 Integrin profiling in integrin-depletion cell lines 
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To perform CEACAM profiling in wildtype AGS/KatoIII and their integrin-depletion cell 
lines, CEACAM expression was analyzed by flow cytometry after staining them with 
CEACAM1, CEACAM5 and CEACAM6 antibodies. Among them, wildtype AGS and 
KatoIII cells stained with CEACAM antibodies were used as positive controls, and all 
tested cell lines were stained with the secondary antibodies alone as the negative 
controls.  
As indicated in Figure 2.15 A, CEACAM profiling in the wildtype AGS and the five 
integrin-depletion AGS cell lines revealed low expression levels of CEACAM1 and 
CEACAM5, and relatively high expression levels of CEACACM6. In addition, integrin 
depletion in AGS cells did not influence CEACAM1 and CEACAM5 expression levels, as 
each integrin-depletion cell line showed equally expressed CEACAM1 or CEACAM5 
when compared to wildtype AGS cells. However, the ITGAv KO AGS cell line showed 
significantly reduced expression of CEACAM6 (P<0.05) when compared to AGS cells. 
Thus, depletion of the αv integrins expression on AGS cells can significantly affect 
CEACAM6 expression levels.  
As shown in Figure 2.15 B, CEACAM profiling in the wildtype KatoIII cells and seven 
integrin-depletion KatoIII cell lines revealed low expression levels of CEACAM1, and 
relatively high expression levels of CEACACM5 and CEACAM6. In addition, depletion of 
one or more integrins in KatoIII cells did not lead to varying CEACAM1 expression. 
However, CEACAM5 and CEACAM6 expression varied markedly amongst different 
integrin knockout cell lines. Particularly, the ITGB4 KO KatoIII cells showed a drastic 
decrease in CEACAM5 (P<0.05) and CEACAM6 (P<0.001) expression and therefore had 
the lowest expression of CEACAM5 and CEACAM6 of all cell lines. Moreover, the 
ITGAvB1 KO KatoIII cells displayed a marked reduction in CEACAM5 (P<0.05) and 
CEACAM6 (P<0.001) as well, and represent the cells with the second lowest CEACAM5 
and CEACAM6 expression. However, the ITGAvB1B4 KO KatoIII cells didn’t show a 
significant decrease in CEACAM5 expression, but did in CEACAM6 (P<0.001). Taken 
together, the genetic inactivation of certain integrin genes in KatoIII cells did strongly 
influence the expression levels of certain CEACAMs, especially CEACAM5 and 
CEACAM6.  
2.4.2  CEACAM profiling in integrin knockout cell lines 
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Figure 2.15 CEACAM expression profiling in different integrin-depletion cell lines. AGS or KatoIII 
wildtype cells and their integrin-depletion cells were stained with antibodies to quantify CEACAM 
expression by flow cytometry. Cells stained with secondary antibody alone were used as negative 
controls. A, CEACAM profiling in integrin-depletion AGS cell lines (n=3). B, CEACAM profiling in 
integrin-depletion KatoIII cell lines (n=3). All values in A and B are depicted as standard errors of 
the mean (±SEM) from three independent experiments. The significance of differences was 
analyzed using One way ANOVA (***P<0.001, **P<0.05). 
A particularly interesting observation was that although the ITGB4 KO KatoIII cell line 
produced extremely low levels of all CEACAMs, it had a full capacity for CagA 
translocation, as compared to the KatoIII wildtype cell line. In addition, the ITGAvB1 KO 
KatoIII cells showed a significantly reduced CagA translocation, but the ITGAvB1B4 KO 
KatoIII cells didn’t. These discrepancies led us to examine whether CEACAM expression 
might change upon H.pylori infection. To this end, KatoIII and its integrin-depletion cell 
lines were infected for 3h with P12 wildtype, P12ΔhopQ or left uninfected, and 
subsequently stained with different CEACAM antibodies. As shown in Figure 2.16 A & C, 
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after infection with either strain, CEACAM1 and CEACAM6 expression pattern in each 
cell line didn’t change before and after H.pylori infection. However, as indicated in 
Figure 2.16 B, CEACAM5 expression in each cell line did increase after infection with 
P12 wildtype, but with varying degree. Among them, KatoIII, the ITGB1 KO KatoIII and 
ITGAv KO KatoIII cell lines showed a two to three fold increase of CEACAM5 expression. 
The ITGB1B4, ITGAvB4 and ITGAvB1B4 knockout KatoIII cell lines showed a one to two 
fold increase of expression. Moreover, CEACAM5 expression was certainly increased in 
ITGAvB1 KO KatoIII cell line, but not as much as in the ITGB4 KO KatoIII cell line. In 
addition, this increase or upregulation of CEACAM5 expression was HopQ dependent, 
since infection with the isogenic hopQ deletion mutant of strain P12 did not change the 
CEACAM5 expression pattern as compared to the non-infected control. These changed 
expression levels of CEACAMs influenced the CagA translocation efficiency accordingly. 
The details will be discussed in section 3.3. 
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Figure 2.16 CEACAM profiling in different integrin-depletion cell lines upon H.pylori infection 
(n=3). KatoIII and its different integrin-depletion cell lines were infected either with P12 wildtype 
strain or P12ΔhopQ for 3h, or left without infection. Afterwards, cells were stained with specific 
antibodies for CEACAM surface expression detection by flow cytometry. Cells stained with only 
secondary antibody in different conditions were considered as negative controls. A, the 
CEACAM1 profiling. B, the CEACAM5 profiling. C, the CEACAM6 profiling. Error bars indicate ±
SEM from three independent experiments and the significance was analyzed by one way ANOVA 
(***P<0.001, **P<0.05) 
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3  Discussion 
3.1 Generation of integrin-depletion cell lines 
Generation of integrin-depletion cell lines was the first step to characterize the role of 
integrin in CagA translocation. Five of the planned integrin-depletion AGS cell lines 
(integrin β1, αv, β4, αvβ4, β1β4 KO AGS) were established successfully with the 
double-nicking strategy. Unfortunately, the other two of the planned integrin αvβ1 KO 
AGS and integrin αvβ1β4 KO AGS cell lines could not be generated. After looking into 
the integrin mediated functions, we realized that adhesion of integrins and their 
extracellular matrix ligands is essential for cell proliferation and survival [161-163]. This 
integrin-mediated cell survival can be disrupted by the absence of integrin-ECM 
ligation. As a result, an apoptosis pathway “anoikis” is triggered. Anoikis, a Greek word 
meaning “homelessness”, is a tissue architecture surveillance mechanism to make sure 
that the dissociated and displaced cells are effectively removed, in order to prevent 
dysplastic growth of mainly epithelial and endothelial cells [163-166].  
So, how does absence of integrin trigger anoikis? To understand this, we first need to 
understand how integrin-ECM adhesion supports cell survival. Integrins are intimately 
coupled with many growth factor receptors, and the correct ligation of ECM proteins 
with integrins is the prerequisite for cells to respond to the stimulation by growth factors. 
This phenomenon is therefore defined as the anchorage-dependent cell survival and 
proliferation, and integrin adhesion plays a fundamental role [167-170]. Integrin-ECM 
adhesion can elicit the integrin-mediated intracellular signal transduction pathways 
including anti-apoptotic pathways and pro-survival pathways in the context of 
supporting cell survival. For example, the focal adhesion kinase (FAK) is recruited to 
activate the phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB) pathway to 
promote cell survival by inhibiting the mitochondrial release of cytochrome-C and by 
activating the NF-κB survival pathway [171, 172]. Furthermore, FAK can trigger an 
3.1.1 Generation of integrin-depletion AGS cell lines 
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anti-apoptotic MAPK (mitogen-activated protein kinases) pathway, as a result, pro-
apoptotic proteins Bim and Bad are degraded and downregulated, respectively [173, 
174]. Meanwhile, Integrin-linked kinase (ILK) is another key player in integrin mediated 
signalling pathway. It can activate the pro-survival PI3K/PKB pathway independent of 
FAK, suggesting that both FAK and ILK can support cell survival in parallel with different 
strategies [175, 176]. 
Loss of integrin engagement with ECM can directly disrupt above mentioned integrin 
mediated growth factor receptor activation, as well as several survival signalling events. 
In the absence of integrin-ECM engagement, the PI3K/Akt pathway and MAPK pathway 
are therefore disrupted. As a result, the pro-apoptotic protein Bim and Bad cannot be 
phosphorylated and degraded properly [177]. This can rapidly promote the 
oligomerization of two other pro-apoptosis proteins, Bax and Bak, within the outer 
mitochondrial membrane, which leads to outer mitochondrial membrane 
permeabilization and cytochrome-C release. Ultimately, the apoptotic pathway is 
activated [178]. Of note, the apoptotic pathway caused by absence of integrin-ECM 
and mitochondrial damage, as described here, is defined as the intrinsic pathway of 
anoikis [166]. 
In addition, the loss of integrin-ECM ligation can lead to anoikis via the extrinsic 
pathway. The extrinsic pathway is initiated by the ligation of the extracellular death 
ligand FasL and its transmembrane receptor Fas [179]. Absence of integrin anchorage 
can result in increased expression of the FasL and Fas, as well as decreased 
expression of Fas-mediated signaling antagonist c-Flip [180]. Ligation of Fas and 
FasL can recruit and activate caspase 8. The latter can further activate more caspases, 
like caspase-3 and -7 to trigger cell death [181]. Alternatively, caspase-8 can directly 
activate the pro-apoptotic protein Bid and finally leads to the release of cytochrome-C 
to trigger anoikis [182, 183]. Thus, the intrinsic and extrinsic pathways can be linked at 
this point.  
Therefore, it can be speculated that the reason for the failed generation of integrin αvβ1 
KO AGS and integrin αvβ1β4 KO AGS cells might be anoikis, triggered by the depletion 
of β1 and αv integrins at the same time in AGS cells, which probably led to cell death in 
the targeted cells. 
Discussion 
 
61 
 
Interestingly, all the planned integrin-depletion KatoIII cell lines were successfully 
generated, suggesting that KatoIII cells confer anoikis resistance and can survive 
independently of integrin-ECM anchorage. Indeed, metastatic transformed cancer cells 
like KatoIII cells can develop sophisticated strategies to bypass anoikis, in order to 
facilitate the aggressive metastatic spread of cancer in foreign tissues and organs 
[184].  
The most common strategy exploited by metastatic cancer cells to resist anoikis is to 
induce several oncogenes or activate different proteins in order to constitutively activate 
pro-survival or anti-apoptotic signaling pathways to compensate the loss of integrin 
anchorage.  For example, the phosphatase and tensin homolog (PTEN), a major 
antagonist of pro-surviving PI3K/Akt signaling, is often mutated, down-regulated or 
inhibited in many aggressive cancers to elicit sustained survival signaling [185, 186]. 
Moreover, during epithelial-mesenchymal transition (EMT, a key event in metastatic 
spread of epithelial cells), several genes encoding transcription factors like Snail, Twist 
and NF-κB are induced to facilitate aniokis resistance by transcription of tumor 
promoting genes, which involved PI3K/Akt cascade activation [187-189]. Similarly, the 
tyrosine kinase receptor c-Met is activated during EMT and it plays an important role in 
stimulating PI3K/Akt signaling [190]. Furthermore, the tropomycin-related kinase B 
(TrkB), the most efficient suppressor of anoikis, is often overexpressed in many 
aggressive cancers, especially in gastric cancers [191]. Its anoikis resistance effect is 
achieved through activating PI3K/Akt and MAPK pathways, as well as downregulating 
E-cadherin expression via the induction of Snail and Twist [192-194]. Loss of E-
cadherin can lead to decreased cell-cell adhesion and β-catenin release. The latter can 
function as a transcription factor to induce tumor promoting genes involved in anoikis 
insensitivity and increased cell motility [195]. 
Other strategies exploited by metastatic cancer cells for confering anoikis resistance 
include the exploitation of oxidative stress, hypoxia, and modifications of energetic 
metabolism [196-201]. We can see that cancer cells have developed diverse strategies 
to overcome anoikis and to facilitate its spread. Therefore it is not surprising that KatoIII 
cells, the gastric cancer cells derived from metastatic sites, can survive without integrin 
3.1.2 Generation of integrin-depletion KatoIII cell lines 
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expression, which makes it possible to generate integrin-depletion KatoIII cell lines 
without any integrin expression. 
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3.2 Host cell integrin independent H.pylori  CagA translocation in 
gastric epithelial cell lines 
Translocation of H.pylori CagA into host cells via the type IV secretion system (T4SS) is 
considered as a major risk factor for gastric diseases including gastric cancer. To 
understand the CagA translocation mechanism, especially the transport of CagA across 
the host cell membrane, previous studies have shown that instead of being randomly 
injected into the host cells, CagA is translocated via the host receptor integrin β1. 
However, different interaction mechanisms were proposed. Kowk and colleagues 
proposed that CagL, a type IV secretion system component protein which harbors the 
classical integrin interaction RGD motif, locates on the tip of the T4SS and interacts 
with host cell integrin β1 to trigger CagA translocation into host cells [127]. However, 
the mechanism of how the CagL-integrin β1 interaction leads to CagA translocation still 
remains a mystery. Independently, the study from Jimenez-Soto and colleagues 
showed that instead of CagL, other T4SS components, like CagI, CagY and CagA, can 
directly interact with host cell integrin β1 in an RGD-independent fashion [128]. This 
discrepancy led us to the first hypothesis that integrin β1 might not be the only receptor 
exploited by H.pylori for CagA translocation. Indeed, more lines of evidence came from 
the observation described below. Firstly, besides integrin β1, CagL can interact with 
other integrins, like integrin αvβ3, αvβ5 and αvβ6 [202-205]. Secondly, many integrin 
β1 antibodies targeting different epitopes, integrin β1 ligands and integrin β1 binding 
proteins could not reduce or block CagA translocation. Together, we supposed that 
H.pylori can exploit more host factors than integrin β1, and the possible candidates can 
be other host cell integrins. Therefore, we generated integrin-depletion cell lines with 
the CRISPR-Cas9 system in order to identify other integrins engaged by H.pylori during 
CagA translocation.  
Surprisingly, AGS cells showed CagA translocation independent of many host cell 
integrins upon wildtype H.pylori strain P12[TEM-CagA] infection, as shown in section 
2.2.1. Different integrin-depletion cell lines exhibited comparable CagA translocation 
3.2.1 Host cell integrin-independent H.pylori CagA translocation in AGS 
cells 
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efficiency. Most notably, it is the first study to our knowledge to investigate the role of 
different integrins in H.pylori CagA translocation, which challenged the existing theory. 
The two previous studies identified integrin β1 as the receptor mainly by evaluating 
CagA translocation via detecting phosphorylated CagA in human integrin β1 deficient 
cell lines and human integrin β1 expressing cell lines. For example, the mouse fibroblast 
cells GD25 and mouse epithelial-like cells GE11 were deficient in detecting 
phosphorylated CagA but the human integrin β1 stably transfected GD25β and GE11β 
cells were translocation competent [127, 128]. Similarly, the human promyelocytic 
leukaemia cells HL60 were capable of CagA translocation but the differentiated HL60 
cells lost the ability, since differentiated HL60 showed “integrin switch” from integrin β1 
to integrin β2 [128]. These results strongly suggested that H.pylori can use integrin β1 
as the receptor for CagA translocation. However, the results shown in this study 
revealed that depletion of integrins did not have a significant effect on CagA 
translocation. Neither integrin β1, nor other host epithelial-specific integrins are 
essential as receptors for CagA translocation. To this end, we propose that integrin β1 
can function as a receptor for H.pylori CagA translocation, but it is not the only one that 
the bacteria exploit for this important pathogenicity mechanism. 
As mentioned in the Introduction section 1.4, host cell integrin is not the only known 
receptor involved in CagA translocation, our group recently found that CEACAMs also 
play an important role in this process. So far the molecular mechanism of how HopQ-
CEACAM interaction can contribute to CagA translocation via the type IV secretion 
system is not well understood. There are many possibilities and one of the major 
hypotheses is that the HopQ-CEACAM interaction can further assist T4SS-integrin 
interaction to promote the CagA translocation via a CEACAM-integrin clustering in the 
lipid rafts. Therefore, a hopQ isogenic deletion mutant of strain P12 was used to infect 
integrin-depletion AGS cell lines in order to disrupt the HopQ-CEACAM interaction, 
since HopQ is the only H.pylori interacting partner for CEACAMs identified so far. We 
hypothesized that host cells can be deprived of CagA translocation ability when both 
integrins and CEACAMs do not function properly as receptors for H.pylori. However this 
was not the case. Again, all five integrin-depletion cell lines showed comparable CagA 
translocation efficiency as compared to AGS cells, meaning that integrin depletion did 
not affect CagA translocation outcome. The results consistently suggested that host cell 
integrins are not essential for CagA translocation. Of note, AGS and the integrin-
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depletion cell lines exhibited reduced CagA translocation efficiency upon P12Δ
hopQ[TEM-CagA] infection, suggesting that beside CEACAMs, H.pylori must have 
exploited other host factors instead of host cell integrins to translocate CagA.   
Nevertheless, some limitations in this assay are worth noting. The CagA translocation 
efficiency in integrin αvβ1 and integrin αvβ1β4 knockout AGS cell lines could not be 
investigated due to the anoikis effects in these two cell lines, as mentioned before in 
section 3.1.1. Therefore, CagA translocation was evaluated in integrin-depletion KatoIII 
cell lines. 
Similarly, CagA translocation efficiency was evaluated and quantified in seven integrin-
depletion KatoIII cell lines in order to assess the role of different host cell integrins in 
CagA translocation. One of the cell lines, integrin αvβ1 knockout KatoIII, showed a 
significantly reduced CagA translocation as compared to AGS cells upon wildtype 
P12[TEM-CagA] infection. All other depletion cell lines exhibited approximately similar 
level of CagA translocation as AGS cells. It was difficult to understand the observation 
that depletion of αv and β1 integrins in KatoIII cells can lead to reduced CagA 
translocation, but depletion of all possible integrins in the integrin αvβ1β4 knockout 
KatoIII cells cannot. This discrepancy led us to presume that depletion of certain 
integrins can affect expression levels of other receptors, like the remaining integrins or 
the CEACAMs, and the CagA translocation outcome can be changed. Therefore, we 
checked integrin and CEACAM expression in each integrin-depletion KatoIII cell line to 
see whether the cells can compensate the loss of certain integrins with other receptors, 
like remaining integrins or CEACAMs. Indeed, the expression levels of integrin and 
CEACAM were affected, especially CEACAMs. The detailed information will be 
discussed in the next section 3.3.  
However, all integrin-depletion cell lines as well as KatoIII cells, showed extremely low 
levels of CagA translocation when infected with the isogenic hopQ deletion mutant 
strain, suggesting that H.pylori mainly utilizes the outer membrane protein HopQ to 
interact with host CEACAMs for CagA translocation in KatoIII cells. This was different 
3.2.2 Host cell integrin-independent H.pylori CagA translocation in KatoIII 
cells 
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from AGS cells, where the HopQ-CEACAM interaction only accounted for roughly half of 
the CagA translocation. However, the molecular mechanism for this phenomenon is 
unclear. A possible explanation could be the lack of (an) unknown co-receptor(s) in 
KatoIII cells. Nevertheless, the results indicated that neither individual integrin nor 
combination of different integrins were essential for CagA translocation. 
Taken together, the results provided compelling and convincing evidence that host cell 
integrins were not essential for H.pylori CagA translocation, as demonstrated by the 
highly sensitive β-lactamase reporter assay. Next, the question was addressed whether 
the host cell integrin independent CagA translocation was a strain specific effect from 
H.pylori strain P12.  
Therefore, three other H.pylori strains with distant geographic origins were tested in two 
representative integrin-depletion cell lines, integrin αvβ1 knockout and integrin αvβ1β4 
knockout KatoIII cell lines, to examine CagA translocation by detecting phosphorylated 
CagA in the infected cell lysates via immunoblot. After infection with three different 
H.pylori strains, the phosphorylated CagA band can be detected in each sample 
(except the negative controls), suggesting that the obtained integrin-independent CagA 
translocation was not a P12 strain-specific effect, but a common phenomenon of 
diverse H.pylori strains. However, the use of immunoblot as a quantification method to 
define the subtle differences in expression of target proteins is still under debate. It is 
reported that approximately 25% of published papers contained misleading or 
inappropriate western blotting quantifications [158]. Therefore, the western blot results 
presented here was not quantified, and the CagA translocation quantification in each 
integrin-depletion cell line was performed using the highly sensitive β-lactamase 
reporter system in this study.  
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3.3 Influence of host cell integrin depletion on other host cell 
receptors and the consequences for the CagA translocation.  
To investigate whether depletion of integrins can affect the expression level of other 
receptors which are potentially involved in CagA translocation, like CEACAMs and the 
remaining integrins, we performed expression profiling of CEACAMs and integrins by 
flow cytometry. We were interested whether the expression level of αv integrins, β4 
integrin and/or CEACAMs might be increased in the context of β1 integrins depletion. If 
this would be the case, it could be explained that the elevated expression level of other 
host receptors compensated the loss of β1 integrin to maintain CagA translocation 
efficiency. However, the outcome was different than the above proposed scenario. 
The β-lactamase reporter assay revealed that integrin depletion did not affect CagA 
translocation efficiency in AGS cells. Meanwhile, integrin profiling results showed that 
remaining integrin expression levels in each integrin-depletion AGS cell line did not 
change significantly as compared to AGS cells. This result confirmed that the depletion 
of certain integrins did not have an influence on CagA translocation efficiency. 
Moreover, it excluded the possibility that depletion of certain integrins led to elevated 
expression levels of remaining integrins, which might have compensatory effects on 
CagA translocation. 
The next question was whether the depletion of integrins in AGS cells can lead to 
elevated expression levels of CEACAMs? Unexpectedly, the CEACAM6 expression in 
one of the integrin-knockout cell lines was significantly reduced. To begin with, the 
CEACAM1 and CEACAM5 detection by flow cytometry revealed very low and nearly 
equal expression levels in AGS cells and the integrin-depletion cell lines. However, 
CEACAM6 expression in each cell line was high, suggesting that HopQ may exploit 
CEACAM6 to support CagA translocation in AGS cells. Among depletion cell lines, 
integrin αv knockout AGS cells exhibited a significantly decreased CEACAM6 
expression. In theory, CagA translocation efficiency should be compromised when the 
3.3.1 Expression profiling of integrins and CEACAMs in integrin-depletion 
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receptor CEACAM6 has reduced expression. However, like other cell lines, the integrin 
αv knockout cell line showed normal CagA translocation without reduction. This was 
unexpected but not surprising, since the HopQ-CEACAM interaction only accounts for 
half of the CagA translocation in AGS cells. A 50% reduced CEACAM6 expression can 
lead in theory to one fourth of the CagA translocation reduction, which might be 
statistically insignificant. In addition, the host pathogen interaction is complicated in the 
infection process. It is possible that the HopQ-CEACAM interaction can assist the 
interaction of the T4SS and some unknown receptors other than integrins, and the 
unknown receptor can compensate the reduction of CEACAM6. Furthermore, it is also 
possible that the reduced CEACAM6 expression was still above the threshold needed for 
CagA translocation, therefore the CagA translocation efficiency was not compromised.   
Taken together, depletion of β1 integrins, αv integrins or β4 integrin (integrin α6β4) did 
not influence CagA translocation in AGS cells. More importantly, depletion of 
combinations of β1 integrins and β4 integrin, or αv integrins and β4 integrin did not 
influence as well. 
3.3.2 Expression profiling of integrins and CEACAMs in integrin-depletion 
KatoIII cell lines 
Similarly, integrin and CEACAM profiling was also performed in integrin-depletion KatoIII 
cell lines to understand the obtained CagA translocation result. Unlike AGS cells, KatoIII 
cells showed a largely changed expression level of other receptors in the context of 
depletion of integrin(s). To begin with, integrin β1 knockout KatoIII cells showed a 
deceased integrin αv and integrin β4 expression; Integrin αv knockout KatoIII cells 
showed reduced integrin β4 expression; Moreover, integrin αvβ1 knockout KatoIII cells 
showed declined integrin β4 expression. Interestingly, CagA translocation efficiency was 
compromised in integrin αvβ1 knockout KatoIII cell line, but not in integrin β1 and 
integrin αv knockout cell lines. Taken together, these results revealed that depletion of 
β1 integrins, and reduced expression of αv integrins and β4 integrin in the integrin β1 
knockout KatoIII cell line had no influence on CagA translocation. Similarly, depletion of 
αv integrins and reduced expression of β4 integrin in the integrin αv knockout cell line 
had no influence in CagA translocation. So far these results indicated that either 
absence or decreased expression of integrins did not have an effect on CagA 
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translocation. Therefore the question was addressed whether depletion of αv and β1 
integrins and reduced integrin β4 expression in the integrin αvβ1 knockout KatoIII cell 
line was accounted for the reduced CagA translocation efficiency in the integrin αvβ1 
knockout KatoIII cell line. Obviously, this was not the reason since the integrin αvβ1β4 
knockout KatoIII cell line exhibited statistically non-reduced CagA translocation 
efficiency. Thus, there must be other reasons for the reduced CagA translocation in the 
integrin αvβ1 knockout KatoIII cell line. Therefore, the CEACAM expression profiles were 
next analyzed. 
Indeed, both CEACAM5 and CEACAM6 expression were markedly decreased to almost 
background level in the integrin αvβ1 knockout KatoIII cell line. Moreover, CEACAM6 
expression was significantly reduced in integrin αvβ1β4 knockout KatoIII cells. Of note, 
the CEACAM expression pattern in KatoIII cells was different from AGS cells. A very low 
expression level of CEACAM1, but a high expression of CEACAM5 and CEACAM6 
suggested that H.pylori principally uses CEACAM5 and CEACAM6 to translocate CagA 
in KatoIII cells. Therefore, dramatically decreased CEACAM5 and CEACAM6 might be 
the reason for reduced CagA translocation efficiency in the integrin αvβ1 knockout 
KatoIII cell line. Moreover, although CEACAM6 expression was strongly reduced in the 
integrin αvβ1β4 knockout KatoIII cell line, CEACAM5 did not change significantly and 
this could be the reason for maintaining CagA translocation at the normal level in the 
integrin αvβ1β4 knockout KatoIII cell line.  
However, it was discussed in section 3.2.2 that the HopQ-CEACAM interaction 
accounted for most of the CagA translocation in KatoIII cells. In this case due to poorly 
expressed CEACAM1, CEACAM5 and CEACAM6, CagA translocation in integrin αvβ1 
knockout KatoIII cells should be diminished to very low levels instead of an only 
approximately 40% reduction. In addition, it was surprising to observe that integrin β4 
knockout KatoIII cells expressed equal but extremely low levels of CEACAM5 and 
CEACAM6, which were similar as the background level, although the cells exhibited 
indistinguishable CagA translocation efficiency as the positive control KatoIII cells. 
These discrepancies led us to assume that CEACAMs expression might be changed 
during the H.pylori infection. Indeed, CEACAM5 expression levels in all cell lines 
increased two to four folds after three hours of infection with strain P12, and the effect 
was HopQ-dependent, since the hopQ deletion mutant failed to increase CEACAM5 
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expression. Among them, CEACAM5 expression elevated two fold in the integrin αvβ1 
knockout cell line and four fold in the integrin β4 knockout cell line. Therefore, it was 
highly possible that CEACAM5 expression reached the threshold needed for full capacity 
of CagA translocation in integrin β4 knockout cells, but not in integrin αvβ1 knockout 
cells.  
Taken together, we have shown a host cell integrin independent CagA translocation in 
AGS and KatoIII cells. Furthermore, integrin depletion in KatoIII cells can change 
CEACAM expression levels and CagA translocation efficiency can be influenced by 
fluctuations in CEACAM expression. 
As mentioned above, it was surprising to discover that the CEACAM expression level, 
especially CEACAM5 and CEACAM6, was decreased in the absence of certain integrins. 
interestingly, CEACAM5 expression was increased during H.pylori infection. Which 
molecular events underlie these two different outcomes in the cellular state? 
In order to explain why integrin depletion can lead to decreased expression level of 
CEACAMs, a literature search was performed, but unfortunately, no direct evidence was 
found. However, it is known that integrins are full-fledged signal transduction receptors 
mediating many important cellular events, as mentioned in section 1.3 and section 3.1. 
Of note, integrin is linked with many transcription factors involved in up- or down-
regulation of many genes, which are linked to cell proliferation, cell motility, cytoskeletal 
organization and cancer progression [101, 107, 109, 206]. Depletion of integrin 
surface expression can certainly disrupt many signal transduction pathways and 
therefore affect transcription of many genes. Therefore, it is feasible that integrin 
depletion may result in changing expression levels of CEACAMs. For example, an 
affymetrix GeneChip assay identified 538 genes the expression of which was regulated 
by integrin α6β4, including genes involved in cell motility, adhesion molecules, 
metastasis, metabolism, apoptosis, and other signaling molecules [207]. Although 
CEACAMs were not on this affymetrix GeneChip list, it is possible that CEACAMs are 
regulated by integrins indirectly. Furthermore, it is puzzling that integrin β4 knockout 
3.3.3 Changing expression levels of host receptors in certain integrin-
depletion cell lines 
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KatoIII cells markedly suppressed CEACAM5 and 6 expression, but integrin β1β4 
knockout cells failed to suppress. Similarly, Integrin αvβ1 knockout KatoIII cells 
exhibited significantly decreased CEACAM5 expression, but integrin αvβ1β4 knockout 
cells didn’t. Again, this study is the first to report these observations and no published 
data are available to explain the exact mechanisms underlying these phenomena. 
However, it is definitely interesting for future researches. 
On the other hand, it is observed that H.pylori infection could induce elevated 
CEACAM5 expression in KatoIII cells and this effect was HopQ dependent. This was an 
exciting finding, suggesting that not only can HopQ bind to CEACAM5, but also induce 
the CEACAM5 upregulation for a better binding and enhanced H.pylori pathogenesis. 
Unfortunately, this effect was not reproducible in other gastric epithelial cells, like AGS, 
MKN45 and ST23132 cell lines [142], suggesting that this was a KatoIII-specific effect 
which may not be true in the in vivo infection process.  
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3.4 Proposed models for transport of CagA across the host cell 
membrane 
In this study, we report for the first time an integrin-independent CagA translocation of 
H.pylori. CagA translocation efficiency was not affected by presence or absence of host 
cell integrin, but by CEACAM expression levels. These results confirm that HopQ can 
function as a non-T4SS contributor in CagA translocation, and meanwhile suggest that 
host cell integrin is not essential in this process.  
Other than integrins, independent studies identified different host factors which were 
involved in CagA translocation. For instance, Lai and colleagues proposed that host 
membrane cholesterol was essential in CagA translocation, since depletion of 
cholesterol resulted in significantly reduced CagA translocation in AGS cells, as 
introduced in section 1.4.1 [129]. However, depletion of host cholesterol can have 
many side effects. Therefore it is hard to distinguish whether reduced CagA 
translocation was caused by absence of cholesterol, or other side effects. Moreover, 
depletion of host cell cholesterol results in lipid raft disruption, and many cellular 
receptors are lipid raft associated like integrins, growth factor receptors and CEACAMs. 
Thus it is likely that cholesterol depletion affected raft-associated receptors which are 
important for CagA translocation. In addition, Murata-Kamiya and colleagues reported 
that CagA can directly interact with host phosphatidylserine to translocate CagA into 
MDCK cells [131], as introduced in section 1.4.1. However, the molecular mechanism 
of CagA-bound phosphatidylserine flipping back to the inside of cells is not well 
understood, and the follow-up researches should be included to explain the interaction 
mechanisms.  
Based on the current literature and the data from this work, the following working 
models regarding H.pylori host-pathogen interaction for CagA translocation are 
proposed (Figure 3.1). Outer membrane protein HopQ, by binding host CEACAMs, 
provides one of the initial signals to recruit other unknown receptors for binding T4SS 
and/or CagA to translocate CagA into host epithelial cells. Such unknown host cell 
receptors may be the reported cholesterol, phosphatidylserine, or other uncharacterized 
raft-associated cellular receptors (Figure 3.1 A). 
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Figure 3.1 Proposed working models for H.pylori CagA translocation regarding host-pathogen 
interaction.  A, Outer membrane protein HopQ, by binding host CEACAMs, provides one of the 
initial signals to recruit other unknown receptors for binding T4SS and/or CagA to translocate 
CagA into host epithelial cells. The unknown host receptors may be the reported cholesterol, 
phosphotidylserine or other uncharacterized raft-associated cellular receptors. B, HopQ. 
CEACAMs and certain T4SS components can form an interaction complex stabilizing each other, 
to facilitate CagA translocation via host CEACAMs. 
However, in some cases the situation is different. The HopQ-CEACAM interaction 
appears to be the major prerequisite in CagA translocation. For example, CagA 
translocation efficiency is diminished to extremely low level in KatoIII cells, as revealed 
by CagA translocation BLA reporter assay upon infection with hopQ deletion mutant in 
this study. This is consistent with the finding that CagA cannot be translocated into 
MKN45 and HEK293 cells when the HopQ-CEACAM interaction was interrupted, or 
CEACAMs were not expressed on the cell surface [142]. Besides the possibility 
proposed above, it is also likely that these cell lines lack additional receptors and 
CEACAMs become the major receptors for CagA translocation. Therefore, we propose 
that HopQ, CEACAMs and certain T4SS components may form an interaction complex 
stabilizing each other, to facilitate CagA translocation via host CEACAMs. In this case, 
the absence of HopQ can lead to an unstable complex of T4SS-CEACAM. As a result, 
CagA translocation is disrupted or abolished (Figure 3.1B). However, future work is 
needed to consolidate and optimize these models.  
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3.5 Outlook 
The data presented in this thesis suggest an integrin-independent CagA translocation 
process in AGS and KatoIII cells. However, the possibility that non-epithelial integrins, 
like leukocyte specific integrins and/or even the platelet integrin are expressed on these 
gastric epithelial cancer cell lines cannot be excluded. It is a common strategy for 
cancer cells to change in their pattern of integrin expression in order to express the 
correct integrins to survive in a different environment for their aggressive metastatic 
growth and spread. For example, while normal squamous cells express integrin α2β1, 
α3β1 and α6β4, the squamous carcinoma cells express high level of integrin αvβ5, αvβ6 
[208, 209]. Melanoma cells are reported to over-express integrin αvβ3, which is not the 
case in normal melanocytes [210, 211]. However, we don’t have direct evidences that 
epithelial cancer cells can “switch” from epithelial integrins to leukocyte integrins. 
Although not very likely, possibility that leukocyte integrins or even the platelet integrin α
IIbβ3 are expressed on the AGS and KatoIII cells which might take over the responsibility 
for CagA translocation has to be excluded in future experiments. 
Similarly, the presence of unusual or undiscovered αβ association of integrin in the two 
cancer cell lines (AGS and KatoIII) was not determined yet. Although the chance is 
extremely low, it is worth checking by using more integrin antibodies in future to make 
sure that no unexpected integrins are expressed on the AGS and KatoIII cell lines. 
Disruption of HopQ-CEACAM interaction can lead to moderate to strong reduction of 
CagA translocation [142]. Besides the fact that CEACAMs can function as receptors for 
CagA translocation, they also act as the adhesin receptors of HopQ for H.pylori to 
adhere on the cell surface [141]. Bacteria cannot bind to the cells properly when the 
HopQ-CEACAM interaction is interrupted, thus the T4SS cannot translocate CagA 
appropriately. Therefore, to better understand the role of bacteria adhesion and its 
effect on CagA translocation, more binding data and mutagenesis studies should be 
included in future to elucidate the role of CEACAMs for CagA translocation.  
Most importantly, as illustrated in Figure 3.1A, the identification of the unknown host 
receptors exploited by H.pylori for CagA translocation is important. However, the search 
for the binding partner(s) for the H.pylori T4SS is complicated, the future work should 
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be performed in a more cooperative way to reveal the molecular mechanisms underlying 
the host-pathogen interaction and CagA translocation. 
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4 Materials and Methods 
4.1 Materials 
4.1.1.1 Helicobacter pylori strains 
Table 4.1 H. pylori strains used in this study 
H. pylori strains Description 
P12  The Clinical isolate from the University of Hamburg 
(isolate number: 888-0) [212] 
 
G27 The clinical isolate from an endoscopy patient in Tuscany, 
Italy [213] 
P12ΔhopQ hopQ gene knockout mutant in P12 strain 
P12ΔcagI cagI gene knockout mutant in P12 strain 
P12[TEM-CagA] CagA fusion protein fused with β-lactamase TEM-1 in P12 
strain 
P12ΔcagI[TEM-CagA] cagI gene deletion mutant in P12[TEM-CagA]  
P12ΔhopQ[TEM-CagA] hopQ gene deletion mutant in P12[TEM-CagA] 
4.1.1.2 Escherichia coli strains 
Table 4.2 E.coli strains used in this study 
E.coli strains Genotypes 
4.1.1 Bacterial strains 
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DH 5 
F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 
(rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
One shot® Top 10 
F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara leu) 7697 galU galK rpsL (StrR) endA1 nupG 
One shot® Stbl3 
F-mcrB mrrhsdS20(rB
-, mB
-) recA13 supE44 ara-14 galK2 lacY1 
proA2 rpsL20(StrR) xyl-5 λ-leumtl-1 
 
Table 4.3 Plasmids created in this study  
Plasmid Genotype/description 
PX462 pSp-Cas9n(BB)-2A-Puro (Addgene ID: 48140) 
pZQ30 PX462 + 8081 (CRISPR constructs targeted on integrin β1 exon 5) 
pZQ31 PX462 + 8283 (CRISPR constructs targeted on integrin β1 exon 5) 
pZQ32 PX462 + 9596 (CRISPR constructs targeted on integrin αv exon 4) 
pZQ33 PX462 + 9798 (CRISPR constructs targeted on integrin αv exon 4) 
pZQ34 PX462 + 12 (CRISPR constructs targeted on integrin β4 exon 6) 
pZQ35 PX462 + 34 (CRISPR constructs targeted on integrin β4 exon 6) 
 
Table 4.4 Oligonucleotides used in this study 
Name Sequence (5' to 3') Description 
4.1.2 Plasmids 
4.1.3 Oligonucleotides 
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ZQ66 GAGGGCCTATTTCCCATGATTCC 
U6 forward primer, for sequencing of 
sgRNA constructs 
ZQ80 CACCGAGTTCTGTTCACTTGTGCAA 
top oligo for targeting integrin β1 exon 5 
(guide A) 
ZQ81 AAACTTGCACAAGTGAACAGAACTC 
bottom oligo for targeting integrin β1 exon 
5 (guide A) 
ZQ82 CACCGGTGCTCAGTCTTACTAATAA 
top oligo for targeting integrin β1 exon 5 
(guide B) 
ZQ83 AAACTTATTAGTAAGACTGAGCACC 
bottom oligo for targeting integrin β1 exon 
5 (guide B) 
ZQ93 CACCGGTGCAGTCCGAGTTGCTAAT top oligo for targeting integrin αV  exon 5 
ZQ94 AAACATTAGCAACTCGGACTGCACC 
bottom oligo for targeting integrin αV  
exon 5 
ZQ95 CACCGCAGTTCTCCAATGGTACAAT 
top oligo for targeting integrin αV  exon 4 
(guide A) 
ZQ96 AAACATTGTACCATTGGAGAACTGC 
bottom oligo for targeting integrin αV  
exon 4 (guide A) 
ZQ97 CACCTAAACAGGAGCGAGAGCCTGT 
top oligo for targeting integrin αV  exon 4 
(guide B) 
ZQ98 AAACACAGGCTCTCGCTCCTGTTTC 
bottom oligo for targeting integrin αV  
exon 4 (guide B) 
CU1 CACCGAAATCCAATAGTGTAGTCGC 
top oligo for targeting integrin β4  exon 6 
(guide A) 
CU2 AAACGCGACTACACTATTGGATTTC 
bottom oligo for targeting integrin β4  
exon 6 (guide A) 
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CU3 
CACCGGCGTCCCGCAGACGGACAT
G 
top oligo for targeting integrin β4  exon 6 
(guide B) 
CU4 AAACCATGTCCGTCTGCGGGACGCC 
bottom oligo for targeting integrin β4  
exon 6  (guide B) 
 
4.1.4.1 Primary antibodies 
Table 4.5 Primary antibodies used in this study 
Name Specificity Origin Supplier 
Anti-phosphotyrosine 
antibody (clone 4G10) 
phosphotyrosine-containing 
proteins 
mouse Millipore 
Anti-phosphotyrosine 
antibody (PY99) 
phosphotyrosine-containing 
proteins  
mouse 
Santa Cruz 
Biotechnology 
Anti-integrin β1 (clone 
LM534) 
human integrin β1 (aa 588-
706)  
mouse Chemicon 
Anti-CD29,FITC (clone 
Ha2/5) 
extracellular domain of 
human integrin  β1 
hamster BD Biosciences 
Anti-β1 chicken Integrin 
(Clone W1B10) 
extracellular part of the 
chicken integrin β1  
mouse Sigma 
Anti-Integrin α1 antibody 
(Clone FB12) 
 human Integrin α1 mouse Chemicon 
Anti-Integrin α2 antibody 
(clone P1E6) 
 human Integrin α2 mouse Chemicon 
Anti-Integrin α3 antibody 
(clone P1B5) 
 human Integrin α3 mouse Chemicon 
Anti-Integrin α4 antibody 
(clone P1H4) 
 human Integrin α4 mouse Chemicon 
4.1.4 Antibodies 
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Anti-Integrin α5 antibody 
(clone P1D6) 
 human Integrin α5 mouse Chemicon 
Anti-Integrin α6 antibody 
(clone NKI-GoH3) 
 human Integrin α6 mouse Chemicon 
Anti-Integrin αV antibody 
(clone P2W7) 
human Integrin αv mouse 
Santa Cruz 
Biotechnology 
Anti-integrin β4antibody 
(clone 439-9B) 
human integrin β4 rat Abcam 
Anti-CEACAM1 antibody 
(clone 8G5) 
human CEACAM1 mouse Genovac 
Anti-CEACAM5 antibody 
(clone 26/3/13) 
human CEACAM5 mouse Genovac 
Anti-CEACAM6 antibody 
(clone 9A6) 
human CEACAM6 mouse Genovac 
 
4.1.4.2 Secondary antibodies 
Table 4.6 secondary antibodies used in this study 
Name Specificity Origen Supplier 
Anti-mouse POX 
(horseradish peroxidase) 
mouse IgG Goat Sigma 
Anti-rabbit POX rabbit IgG Goat Sigma 
Anti-mouse-Alexa488 mouse IgG Goat life technologies 
Anti-rat-Alexa488 rat IgG Goat life technologies 
Anti-rabbit-Alexa488 rabbit IgG Goat life technologies 
 
4.1.5 Cell lines 
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Table 4.7 Cell lines used in this study 
Name Description 
AGS Human Caucasian gastric adenocarcinoma (ATCC
® CRL-1739TM)  
KatoIII Human stomach cancer cell line derived from metastatic site (ATCC® HTB-103TM) 
  
Table 4.8 Stable cell lines created in this study 
Name Description 
ITGB1 KO AGS 
Integrin β1 knockout AGS cell line with depletion of all 12 potential β1 
integrins expression on the cell surface 
ITGAv KO AGS 
Integrin αv knockout AGS cell line with depletion of all 5 potential αv 
integrins expression on the cell surface 
ITGB4 KO AGS 
Integrin β4 knockout AGS cell line with depletion of integrin α6β4  
expression on the cell surface 
ITGB1B4 KO AGS 
Integrin β1 and β4 knockout AGS cell line with depletion of all 12 
potential  β1 integrins and integrin α6β4 expression on the cell surface 
ITGAvB4 KO AGS 
Integrin αv and β4 knockout AGS cell line with depletion of all 5  
potential  αv integrins and integrin α6β4 expression on the cell surface 
ITGB1 KO KatoIII 
Integrin β1 knockout KatoIII cell line with depletion of all 12 potential β1 
integrins expression on the cell surface 
ITGAv KO KatoIII 
Integrin αv knockout KatoIII cell line with depletion of all 5 potential αv 
integrins expression on the cell surface 
ITGB4 KO KatoIII 
Integrin β4 knockout KatoIII cell line with depletion of integrin α6β4  
expression on the cell surface 
ITGB1B4 KO KatoIII 
Integrin β1 and β4 knockout KatoIII cell line with depletion of all 12 
potential  β1 integrins and integrin α6β4 expression on the cell surface 
ITGAvB4 KO KatoIII 
Integrin αv and β4 knockout KatoIII cell line with depletion of all 5  
potential  αv integrins and integrin α6β4 expression on the cell surface 
ITGAvB1 KO KatoIII 
Integrin αv and β1 knockout KatoIII cell line with depletion of all 12 
potential β1 integrins and 5 potential αv integrins expression on the cell 
surface 
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ITGAvB1B4 KO 
KatoIII 
Integrin αv, β1 and β4 knockout KatoIII cell line with depletion of all 
possible integrins on KatoIII cell surface 
 
4.1.6 Enzymes and proteins 
Table 4.9 Enzymes and proteins used in this study 
Name supplier 
T4 polynucleotide kinase New England Biolabs 
PlasmidSafe  ATP-dependent Dnase Epicentre 
T4 DNA ligase New England Biolabs 
High Fidelity PCR Enzyme Mix Life technologies 
Ex Taq DNA Polymerase Takara 
LA Taq DNA Polymerase Takara 
PageRuler Plus Prestained Protein Ladder Pierce 
Rabbit IgG Pierce 
restriction enzymes NEB/Roche/Fermantas 
 
 
 
 
 
4.1.7 Standard buffers 
Table 4.10  Standard buffers used in this study 
Buffer Composition 
PBS 
137mM NaCl, 2.7mMKCl, 10mMNa2HPO4, 1.8mM KH2PO4, 
1mM CaCl2, 0.5mM MgCl2, pH 7.4 
TBS 50mM Tris-HCl pH 7.4, 150mM NaCl 
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50X TAE buffer 242 g/l Tris Base, 57,1 ml/l Glacial Acetic Acid, 50 mM EDTA 
PFA 10X Paraformaldehyde 27%, PBS 10X, pH 7,4 
Anode I buffer 300 mM  Tris-HCl pH 10.4, 10% methonal 
Anode II buffer 25 mM  Tris-HCl pH 10.4, 10% methonal 
Cathode buffer 
25 mM  Tris-HCl pH 9.6, 40mM 6-amino caproic acid, 10% 
methonal 
2X SDS loading buffer 
100 mM Tris HCl pH 6,8; 4% SDS; 0,2% Bromophenol blue, 
20% Glycerol, 10% β-Mercaptoethanol (optional) 
5X SDS loading buffer 
10% SDS; 0,5 M Tris HCl (pH 6,8); 50% Glycerol, 5% 
Bromophenol blue. Store at room temperature. 
GEBS (Agarose Loading 
buffer 6X) 
0,25% Bromophenolblue; 0,25% Xylene Cyanol FF, 30% 
Glycerol; in TAE buffer 
 
 
 
 
4.1.8 Growth medium, antibiotics, reagents, supplements 
Table 4.11 Growth medium, antibiotics, reagents and supplements used in this study 
Name supplier 
Dulbecco's PBS (DPBS) Life technologies 
Opti-MEM I reduced-serum medium Life technologies 
RPMI 1640 Life technologies 
DMEM hign glucose Life technologies 
L-Glutamine Invitrogen 
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Fetal Calf Serum(FCS) Invitrogen 
Trypsin-EDTA (TE) Invitrogen 
Penicillin-streptomycin, 100× Life technologies 
Gentamycin Invitrogen 
Puromycin dihydrochloride Life technologies 
Hygromycin PAA laboratories 
G418 Invitrogen 
Lipofectamine 2000 Life technologies 
 
 
 
  
Table 4.12 Commercial kits used in this study 
Commercial kit Supplier 
SURVEYOR mutation detection kit Transgenomic  
Amaxa cell line Nucleofector Kit V Lonza 
TOPO TA Cloning kit Life technologies 
QIAamp DNA mini kit Qiagen 
QIAprep spin miniprep kit Qiagen 
QIAprep spin midiprep kit Qiagen 
4.1.9 Commercial kits 
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illustra GFX PCR DNA and gel band purification kit GE Healthcare 
Gateway® BP Clonase® II Enzyme mix 
 
Life technologies 
Gateway® LR Clonase® Enzyme mix 
 
Life technologies 
 
4.2 Methods 
4.2.1.1 H.pylori cultivation and maintenance  
H. pylori are capable of growing when cultured on nutrient-rich agars or medium. In this 
study, serum plates and liquid BB medium were used for cultivation. For the serum 
plates, GC agar base was autoclaved and supplemented with horse serum, nystatin, 
trimethoprim, Cholesterol, vitamin mix and/or appropriate antibiotics, while liquid BB 
medium were autoclaved before adding supplements as same as for the serum plates. 
The respective concentration of the supplements is listed below. 
H. pylori strains were defrosted from -70ºC and plated on serum plates. The plates 
were inverted and incubated at 37 ºC under micro aerobic conditions (85% N2, 10% CO2 
and 5% O2) for three days. From the fourth day on, the bacteria were passaged 
everyday on new and fresh plates and 2 passages were needed before infection 
experiments. After 6 passages, the bacteria plates were autoclaved and discarded. H. 
pylori liquid culture was made by inoculating bacteria from plate to 30-50ml BB 
medium and shaking gently under microaerobic condition at 37ºC, 90rpm. 
4.2.1.2 Generation of H.pylori frozen stocks 
Freshly grown H. pylori after the second passage were collected by sterile cotton swabs 
and resuspended in sterile filtrated BB medium with 10% FCS and 25% glycerol. Stocks 
were kept at -70ºC for the long term storage. 
4.2.1 Working with H.pylori 
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4.2.2.1 E.coli cultivation and maintenance 
E.coli is cultivated either on Luria-Bertani (LB) plates or LB liquid medium with 
appropriate antibiotics. From frozen stocks, E.coli were streaked out on LB plates and 
incubated at 37°C for over night. For liquid culture, single colony from plate was 
inoculated to 100ml LB broth with shaking at 200 rpm at 37°C. 
4.2.2.2 Plasmid extraction from E.coli 
Plasmids were extracted from DH5 or Top10 with the QIAprep Spin Miniprep kit 
(Qiagen) following the Qiaprep users handbook. Instead of preparing plamid from liquid 
culture, bacteria grown on LB plates were resuspended in PBS to start the protocol. 
Concentration of the plasmid DNA was quantified by Nanodrop ND-1000 spectrometer 
(Peylab). 
4.2.2.3 Restriction digestion 
Vectors and PCR amplicons were treated with according restriction enzymes before 
ligation. The actual reaction conditions vary from one enzyme to the next, from 
incubation times, buffers to temperature, etc. Generally, total volume of 10µl was 
prepared for each reaction including 300ng to 500ng DNA, 0.5U/µl enzyme and 
corresponding buffer provided by the manufacture. The reaction usually incubated at 
37°C for 1h. 
4.2.2.4 Agarose gel electrophoresis  
Agarose gel electrophoresis is the standard method of separating DNA molecules by 
length in base pairs for demands of DNA visualization and purification. Negative 
charged DNA can move in an electoral field from negative electrode to positive 
electrode. The agarose matrix provided different migration rate for short DNA and long 
DNA. Typically, DNA is mixed with GEBS loading buffer before pipetting to 1% - 2% 
4.2.2 Working with Escherichia coli  
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agarose gel which soaked in the TAE buffer. 80V of voltage was applied until the dye 
line is 2/3 of the way to the bottom. 
4.2.2.5 Ligation 
Digested vectors and insert DNA were ligated by T4 DNA ligase (NEB) at 16 °C for 4h or 
at room temperature for 1h. For efficient ligation, the molar ratio of the insert and 
vector was from 3:1 to 5:1. Generally, 5U of ligase was used for the overall 
concentration of 3-8μg/ml of vector and insert in a total reaction volume of 10µl. 
4.2.2.6 Transformation 
Transformation can allow the introduction of foreign DNA into a cell for plasmids 
storage and replication. Briefly, 10ng to 100ng ligated DNA was added to 20µl ice cold 
competent cells. After 10 min incubation on ice, the mixture was heat shocked at 42°C 
for 30s, followed by immediately returning back to ice for 10min. 200µl LB medium was 
added to the mixture for the outgrowth of the competent cells at 37°C for 1h. Cells were 
then plated on LB plate with appropriate antibiotics depending on the plasmid being 
transformed. 
4.2.2.7  TOPO TA cloning 
TOPO TA cloning provides an efficient method to directly clone PCR fragment into 
TOPO vector without purification of the PCR product and ligation. For each sample, 
50ng fresh PCR product and 1µl salt solution provided by the kit were mixed. Water was 
added to each mixture to a total volume of 5µl. 1µl of the provided Topo vector was 
then added to the mixture with thorough mixing after addition. Each reaction was then 
incubated at room temperature for 5min followed by placing the reaction on ice. 2µl of 
the reaction were directly transformed to Top 10 competent cells by heat shock. After 
the outgrowth, 20µl and 100µl of each transformation were plated on ampicillin or 
kanamycin LB plates.  
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4.2.3.1 Design of short guide RNA 
Design of short guide RNA (sgRNA) for gene targeting was accomplished in an online 
design tool http://toolsgenome-engineering.org developed by Feng Zhang’s lab in 
Broad Institute of Massachusetts Institute of Technology and Harvard. Firstly, a 23 to 
250bp genome fragment from the target region was input to the design tool. After 
computationally analysis, suitable targets were identified and listed with ranking and 
scores, according to the prediction of their off-target potential. Usually, the input region 
of interest should be selected from promoter region or early exons of the target gene. 
Designed sgRNA were modified as described in Figure 2.4 and ordered as oligos 
commercially. It is worth noting that although unusual, certain sgRNAs could not 
properly work as expected for reasons yet unknown [214] . Therefore, in order to obtain 
functional sgRNA, more than one (pair) sgRNAs were designed for each target gene 
and their efficiencies were tested in the intended cell line(s). 
4.2.3.2  CRISPR constructs preparation 
4.2.3.2.1  sgRNA oligos annealing 
In order to acquire sgRNA expressing constructs, top and bottom oligos were annealed 
before cloning (Figure 2.3.B). For each reaction, 100µM top oligo, 100µM bottom oligo 
and 2µl 10×T4 ligation buffer were mixed thoroughly. Water was added to each mixture 
to a total volume of 20µl. Each reaction was incubated in a heating block at 95°C for 
5min followed by placing the block in a cooling room (4-8°C) to allow the temperature 
ramping down naturally. The total annealing time took around 90min. 
4.2.3.2.2  Cloning of sgRNA inserts into CRISPR vector. 
CRISPR vectors used in this study is the Cas9 nickase vector (pSpCas9n(BB)-2A-Puro, 
PX462). The vectors contained the conserve region of the remained sgRNA scaffold, S. 
pyogenes Cas9 nickase, along with the 2A-Puro for transfection selection. Cloning 
started with restriction digestion of the vector. 1µg PX462 were mixed with 1µl 
FastDigest Bpil (Thermo Fischer Scientific) and its 10×FastDigest buffer. Water was 
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added to the mixture to reach volume of 20µl in total. Digestion mixtures were 
incubated at 37°C for 1h. Ligation of vectors with inserts was followed immediately, by 
adding following ligation components directly into digestion reaction: 2.5µl 10XT4 
Ligation buffer (NEB), 0.4µM annealed oligo, and 1.5µl T4 DNA ligase (NEB). After 
incubation at 37ºC for 1h, 2µl of the ligation reaction were directly transformed to 20µl 
ice cold Stbl3 competent cells by heat shock. After the outgrowth, 100µl of each 
transformation were plated on ampicillin LB plates. Colony growth was inspected the 
next day; two to three colonies from each transformation were restreaked for sequence 
verification from the U6 promoter on the vector using U6-Fwd primer (section 4.1.3, 
ZQ66).  
4.2.3.3 Functional validation of sgRNAs 
Functional validation of sgRNAs was completed by transfection of sgRNA expressing 
constructs into target cell lines, followed by verification of genome modification from 
transfected population. In this study, host cell surface expressing integrins are the 
targets of CRISPR-Cas9 mediated gene knockout. Therefore, verification of genome 
modification can be accomplished by flow cytometry surface integrin detection. If the 
transfected population showed two distinct populations with different phenotypes, in this 
case, one of the population with a specific integrin expression and the other without, 
sgRNA(s) were considered valid and efficient.  
4.2.3.3.1  Cultivation and maintenance of cells.  
Cells are generally cultured in RPMI 1640 or DMEM supplemented with 10% (vol/vol) 
FCS at 37°C and 5% CO2. To passage, the medium were removed, and the cells were 
washed once with DPBS gently. To detach cells, 2ml Trypin-EDTA was added to a 
75cm2 flask for 3 to 5min incubation at 37°C. When detachment was observed under 
microscope, 8ml of the pre-warmed RPMI1640 medium were added to neutralize the 
trypsin. After being gently pipetted up and down, cells were dissociated and were then 
reseeded into new flasks. Passages taken place in every 2-3 days with a split ratio of 
1:5 or 1:8. Cells were discarded when the passage number reached 80. 
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4.2.3.3.2  Transfection of adherent/semi-adherent cells by Lipofection 
Generally, one day before transfection, 0.5 x 105 to 2 x 105 cells were plated in 500μl of 
growth medium without antibiotics in a 24-well plate so that they would be 90-95% 
confluent at the time of transfection. For each transfection sample, 500µg DNA was 
diluted in 50μl of Opti-MEM® I Reduced Serum Medium without serum and mixed 
gently. Meanwhile, 2µl lipofectamine 2000 was diluted in 50μl of Opti-MEM® I Medium. 
After 5min incubation at room temperature, the diluted DNA was combined with the 
diluted Lipofectamine 2000 (total volume is 100μl). After gently mix, the mixture was 
incubated for 20min at room temperature to allow the DNA-Lipofectamine 2000 
complexes to form. Add the 100μl of DNA-Lipofectamine 2000 complexes to each well 
containing cells and medium. To ensure thorough mixing, the plate was rocked back 
and forth. The cells were incubated at 37°C in a CO2 incubator for 24-48 hours until 
they were ready to analyse for transgene expression. Usually, it is necessary to remove 
the complexes or change the medium 4 to 6 hours after transfection to improve the 
efficiency. AGS cells were different, and the medium should be changed 45 min after 
transfection. 
4.2.3.3.3  Detection of proteins on cell surface by flow cytometry 
For adherent cells, cells were firstly detached by washing once with DPBS and 
incubated with trypsin-EDTA for 2 to 6min. Trypsinized cells were then neutralized by 
growth medium and 1×106 cells were taken in ice cold FACS buffer ( DPBS containing 
5% FCS and 0.1% sodium azide). For suspension cells, the cell suspension was 
adjusted in a concentration of 1×106ml−1. Around 2×105 cells were add to each well 
with round bottom of a 96-well plate and centrifuge at 4°C of maximum 300×g for 5 
min. Primary antibodies with the concentration of 0.1 to 10µg ml-1 were added to each 
well. Dilutions of antibody, if necessary, were made in FACS buffer. Cells and 
antibodies were incubated at 4°C for 1 hour in the dark.  Primary antibody stained cells 
were washed 3 times by centrifugation at 200-300×g for 5 minutes and were 
resuspended in 200μl to 1ml of ice cold FACS buffer. Subsequently, fluorochrome-
labeled secondary antibodies were diluted in FACS buffer at the optimal concentration 
(according to the manufacture’s instructions) and were added to each well, followed by 
3 times washing as described above. Cells were analyzed by the flow cytometer right 
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after washing or kept in the dark on ice or at 4°C in a fridge until the scheduled time for 
analysis.  
4.2.3.4 Generation of clonal gene-knockout cell lines 
4.2.3.4.1  FACS sorting for desired population 
Generation of clonal cell lines started from FACS sorting for integrin negative population 
from transfected cells. After sorting, most of the cells with undesired phenotype were 
removed, in a way to markedly simplify the time- and labor-consuming selection 
works. Each transfected population was stained with specific antibodies for sorting 
preparation, and the FACS sorting experiments were conducted in Microbiology 
Department of Technical university of Munich. After sorting, cells were cultured in the 
presence of penicillin and streptomycin for one or two weeks until they reached 1×106 
for long term storage by freezing in liquid nitrogen.  
4.2.3.4.2  Isolation of clonal cell lines 
Clonal cell lines which arose from single knockout cells were obtained by performing 
serial dilutions from sorted population. Sorted cells were detached and dissociated by 
pipetting up and down carefully to prevent clumping. Afterwards, cell number was 
determined by counting with a hemocytometer. In order to dilute the cells in a final 
concentration of 1 cell per well in a 96-well plate, 100 cells were resuspended in 22 ml 
complete medium and  200 µl diluted cells were added to each well with multichannel 
pipette. At least two 96-well plates were plated for each sorted population. One to two 
weeks later, colonies in each well were inspected with the microscope, and those wells 
with more than one colony were marked off. Plates were returned to the incubator to 
allow them to grow for another 1 to 2 weeks. The wells with single clones were marked 
and expanded to 48- well plates, then 24-well plates, then 6-well plates and finally 
25cm2 flasks for examine and freezing. For each cell line, four to five single clones were 
selected and examined for specific surface integrin expression by flow cytometry. For 
each cell line, only one of the single clones which showed complete knockout 
phenotype was kept for further culture and investigation.  
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4.2.4.1 SDS-PAGE  
SDS-PAGE, with full name of sodium dodecyl sulfate polyacrylamide gel 
electrophoresis, is the most widely used technique to separate proteins according to 
their molecular weight. Protein samples were collected from transfected or infected 
cells followed by denaturing at 95°C for 10 min and loaded on to a separated gel with 
6% to 12% polyacrylamide percentage separating gel containing a 5% stacking gel. 
After loading, the gel was placed in BioRad electrophoresis chamber filled with SDS 
running buffer. An electrical current was applied to allow the negative charged proteins 
moving toward the positive electrode. Generally, 80 voltage was applied for 30 min to 
allow the proteins to go through the stacking gel, and the voltage was then raised to 
120µl for 60-90 min. Gels were further used for coomassie staining or transfer to PVDF 
membranes. 
4.2.4.2 Transfer  
Proteins with an electoral charge provided by the SDS bounded to them have the ability 
to migrate through the gels into an electoral field. Therefore, transfer of proteins from 
polyacrylamide gels to PVDF membranes was achieved in semi-dry electric transfer 
chamber (Biotech-Fisher). Briefly, the membrane (closed to positive electrode) and the 
gel (closed to negative electrode) were together in between filter papers which were 
previously soaked with Anode I, II or cathode buffers. The current of the electoral 
transfer was maintained at 0.8 mA per 1 cm2 of the gel area for 75 min.  
4.2.4.3 Western blot 
Western blot becomes routine in most biochemistry and biology lab. After separating 
proteins by SDS-PAGE and transferring proteins from the gel to PVDF membranes, 
proteins on the membrane were probed by appropriate antibodies for the demand of 
visualization. Briefly, the membrane was activated by methanol before being blocked 
with 5% skim milk for 2 hours at room temperature. Blots were then incubated with 
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primary antibody with appropriate dilution in 1% slim milk at 4 °C overnight. After proper 
wash with TBS-Tween (TBS-T, 0.075%) for 3 times, blots were incubated with 
secondary antibody with appropriate dilution in 1% slim milk at room temperature. After 
carefully wash with TBS-T for 4 to 5 times, blots were developed by ECL Western Blot 
Developer. Development was done either digitally by Gel Doc (Biorad) or by X-ray film 
developer. Blots were incubated with stripping buffer for 30min after development to 
remove the antibodies bounded to the membrane. After 3 times wash, Blots were then 
dried and reactivated for next round of immunoblotting. 
4.2.4.4 Dot blot 
A dot blot is a fast and easy way to determine the presence and effectiveness of the 
target protein in samples without separating electrophoretically by SDS-PAGE. To start, 
a PVDF membrane was prepared and activated in methanol for 5 sec and kept wet in 
TBS. The total volume of 2 to 5µl sample (10-50ng) was spotted onto the membrane 
by using a pippet tip. After totally dried, the membrane was then briefly activated again 
by methanol before being blocked in 3% BSA in TBS-T for 1 h in room temperature. 
The subsequent procedures like incubation with primary antibody and secondary 
antibody as well as development were the same as described in western blot. 
4.2.4.5 Infection of eukaryotic cells with H.pylori and CagA phosphotyrosine assay 
Two days before infection, 2.5×105 cells were seeded in each well of a 6-well plate to 
reach the confluence of 70-90% on the day of infection. H.pylori strains on agar plates 
which were around 24 hours old were resuspended in DPBS using cotton swabs. After 
measuring the OD550, cells were infected using a Multiplicity Of Infection (MOI) of 60 
(approx. 60 bacteria per cell) for 4 hours at 37°C and 5% CO2. The infection was 
stopped by placing the plates on ice. The supernatants containing bacteria were 
discarded and autoclaved. The infected cells were washed twice with cold PBS to 
remove swimming bacteria. Subsequently, cells were collected carefully by cell scrapers 
after the addition of 1ml fresh made PBS*. After gentle centrifugation at 500×g for 10 
min in 4°C, cell pellets were concentrated in small amount of PBS* solution containing 
2×SDS loading buffer (1:1 ratio). After boiling at 95°C for 10min, cell samples were 
stored at -20°C for later immunoblotting detection of phosphorylated CagA protein. 
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Usually, a mouse polyclonal antibody PY99 or a mouse monoclonal antibody 4G10 was 
used to detect phosphorylated tyrosine in our lab. 
PBS*: PBS with the addition of different proteinase inhibtors as 
follows: 1mM sodium vanadate, 1 mM PMSF, 1 µM 
leupeptin, 1 µM pepstatin 
4.2.4.6  Quantification of CagA translcaotion with plate-reader detection 
One day before infection, adherent cells were detached and 2.5×104 cells were seeded 
in each well in a 96-well plate with black wall and transparent bottom with low 
fluorescence background (Fortitude). The confluence of the cells was 80% to 90% on 
the day of infection. Before infection, H.pylori strains with fusion protein of beta-
lactamase TEM-1 and CagA were collected as described before. Ideally, bacteria were 
resuspended and pre-incubated in sterile PBS containing 10% FCS at 37°C, 10% CO2 
for 1.5h. Subsequently, cells were infected by bacteria with the MOI of 60 for 4 h at 37°
C, 5% CO2 as described above. Shortly before the infections were done, beta-
lactamase substrate was prepared by mixing the fluorescent substrate CCF4-AM with 
solution B, solution C and PBS according to the manufacture’s instruction (Live 
BLAzerTM FRET – B/G loading Kit, Invitrogen). Infections were stopped by placing the 
plates on ice and all the supernatants were removed. Prepared substrates mix was 
loaded immediately on the cell surface, followed by incubation at room temperature for 
120min in dark. Before going to the plate reader, dust was removed from the bottom of 
the plate to make sure the accuracy. Plate reader filters were set to allow excitation of 
wavelength around 410nm, and detection of blue emission around 450nm and green 
emission around 520nm. After reading, data were normalized and analyzed following 
manufacture’s instruction to obtain the blue to green fluorescence ratio.  
4.2.4.7 Quantification of CagA translocation with flow-cytometry detection 
For suspension and semi-adherent cell lines, CagA translocation is possible to be 
detected by flow cytometry as an alternative. The method of CagA translocation assay 
with flow-cytometry detection is very similar to the plate-reader detection except 
following procedures. Firstly, semi-adherent cells were detached after infection with 
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room-temperature trypsin-EDTA before incubation with CCF4-AM fluorescence 
substrate mix. Secondly, incubation of cells with CCF4-AM mix were implemented at 27 
°C with constant shaking condition to allow even loading of cells with substrate and 
avoid cell sedimentation. Last but not the least; cells were washed at least 2 times with 
PBS by centrifugation at 200-300×g for 5 minutes after incubation with CCF4-AM 
substrate. Cells were then analyzed by flow cytometry for pacific blue fluorescence and 
amCyan green fluorescence.  
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